[go: up one dir, main page]

US20070104809A1 - Composition comprising a bacteriocin and an extract from a plant of the labiatae family - Google Patents

Composition comprising a bacteriocin and an extract from a plant of the labiatae family Download PDF

Info

Publication number
US20070104809A1
US20070104809A1 US10/568,324 US56832404A US2007104809A1 US 20070104809 A1 US20070104809 A1 US 20070104809A1 US 56832404 A US56832404 A US 56832404A US 2007104809 A1 US2007104809 A1 US 2007104809A1
Authority
US
United States
Prior art keywords
composition
amount
composition according
extract
nisin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US10/568,324
Inventor
Bob Coyne
John Faragher
Sebastien Gouin
Carsten Hansen
Richard Ingram
Torben Isak
Linda Thomas
Kathryn Tse
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
International N&H Denmark ApS
Original Assignee
Danisco AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0319817A external-priority patent/GB2388581A/en
Priority claimed from GB0323335A external-priority patent/GB0323335D0/en
Application filed by Danisco AS filed Critical Danisco AS
Priority to US10/568,324 priority Critical patent/US20070104809A1/en
Priority claimed from PCT/GB2004/003423 external-priority patent/WO2005018333A1/en
Assigned to DANISCO A/S reassignment DANISCO A/S ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: INGRAM, RICHARD, GOUIN, SEBASTIEN, COYNE, BOB, TSE, KATHRYN LOUISE, FARAGHER, JOHN, HANSEN, CARSTEN BJORN, ISAK, TORBEN, THOMAS, LINDA VALERIE
Publication of US20070104809A1 publication Critical patent/US20070104809A1/en
Assigned to DUPONT NUTRITION BIOSCIENCES APS reassignment DUPONT NUTRITION BIOSCIENCES APS CHANGE OF NAME (SEE DOCUMENT FOR DETAILS). Assignors: DANISCO A/S
Abandoned legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N63/00—Biocides, pest repellants or attractants, or plant growth regulators containing microorganisms, viruses, microbial fungi, animals or substances produced by, or obtained from, microorganisms, viruses, microbial fungi or animals, e.g. enzymes or fermentates
    • A01N63/50—Isolated enzymes; Isolated proteins
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N25/00—Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests
    • A01N25/26—Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests in coated particulate form
    • A01N25/28—Microcapsules or nanocapsules
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N31/00—Biocides, pest repellants or attractants, or plant growth regulators containing organic oxygen or sulfur compounds
    • A01N31/08—Oxygen or sulfur directly attached to an aromatic ring system
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N35/00—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having two bonds to hetero atoms with at the most one bond to halogen, e.g. aldehyde radical
    • A01N35/06—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having two bonds to hetero atoms with at the most one bond to halogen, e.g. aldehyde radical containing keto or thioketo groups as part of a ring, e.g. cyclohexanone, quinone; Derivatives thereof, e.g. ketals
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N37/00—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having three bonds to hetero atoms with at the most two bonds to halogen, e.g. carboxylic acids
    • A01N37/36—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having three bonds to hetero atoms with at the most two bonds to halogen, e.g. carboxylic acids containing at least one carboxylic group or a thio analogue, or a derivative thereof, and a singly bound oxygen or sulfur atom attached to the same carbon skeleton, this oxygen or sulfur atom not being a member of a carboxylic group or of a thio analogue, or of a derivative thereof, e.g. hydroxy-carboxylic acids
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N37/00—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having three bonds to hetero atoms with at the most two bonds to halogen, e.g. carboxylic acids
    • A01N37/36—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having three bonds to hetero atoms with at the most two bonds to halogen, e.g. carboxylic acids containing at least one carboxylic group or a thio analogue, or a derivative thereof, and a singly bound oxygen or sulfur atom attached to the same carbon skeleton, this oxygen or sulfur atom not being a member of a carboxylic group or of a thio analogue, or of a derivative thereof, e.g. hydroxy-carboxylic acids
    • A01N37/38—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having three bonds to hetero atoms with at the most two bonds to halogen, e.g. carboxylic acids containing at least one carboxylic group or a thio analogue, or a derivative thereof, and a singly bound oxygen or sulfur atom attached to the same carbon skeleton, this oxygen or sulfur atom not being a member of a carboxylic group or of a thio analogue, or of a derivative thereof, e.g. hydroxy-carboxylic acids having at least one oxygen or sulfur atom attached to an aromatic ring system
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N37/00—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having three bonds to hetero atoms with at the most two bonds to halogen, e.g. carboxylic acids
    • A01N37/44—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having three bonds to hetero atoms with at the most two bonds to halogen, e.g. carboxylic acids containing at least one carboxylic group or a thio analogue, or a derivative thereof, and a nitrogen atom attached to the same carbon skeleton by a single or double bond, this nitrogen atom not being a member of a derivative or of a thio analogue of a carboxylic group, e.g. amino-carboxylic acids
    • A01N37/46—N-acyl derivatives
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N65/00—Biocides, pest repellants or attractants, or plant growth regulators containing material from algae, lichens, bryophyta, multi-cellular fungi or plants, or extracts thereof
    • A01N65/08—Magnoliopsida [dicotyledons]
    • A01N65/22—Lamiaceae or Labiatae [Mint family], e.g. thyme, rosemary, skullcap, selfheal, lavender, perilla, pennyroyal, peppermint or spearmint
    • A—HUMAN NECESSITIES
    • A21—BAKING; EDIBLE DOUGHS
    • A21D—TREATMENT OF FLOUR OR DOUGH FOR BAKING, e.g. BY ADDITION OF MATERIALS; BAKING; BAKERY PRODUCTS
    • A21D2/00—Treatment of flour or dough by adding materials thereto before or during baking
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23B—PRESERVATION OF FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES; CHEMICAL RIPENING OF FRUIT OR VEGETABLES
    • A23B11/00—Preservation of milk or dairy products
    • A23B11/60—Preservation of cheese or cheese preparations
    • A23B11/65—Preservation of cheese or cheese preparations by addition of preservatives
    • A23B11/67—Preservation of cheese or cheese preparations by addition of preservatives of antibiotics
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23B—PRESERVATION OF FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES; CHEMICAL RIPENING OF FRUIT OR VEGETABLES
    • A23B2/00—Preservation of foods or foodstuffs, in general
    • A23B2/70—Preservation of foods or foodstuffs, in general by treatment with chemicals
    • A23B2/725—Preservation of foods or foodstuffs, in general by treatment with chemicals in the form of liquids or solids
    • A23B2/729—Organic compounds; Microorganisms; Enzymes
    • A23B2/7295—Antibiotics
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23B—PRESERVATION OF FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES; CHEMICAL RIPENING OF FRUIT OR VEGETABLES
    • A23B2/00—Preservation of foods or foodstuffs, in general
    • A23B2/70—Preservation of foods or foodstuffs, in general by treatment with chemicals
    • A23B2/725—Preservation of foods or foodstuffs, in general by treatment with chemicals in the form of liquids or solids
    • A23B2/729—Organic compounds; Microorganisms; Enzymes
    • A23B2/733—Compounds of undetermined constitution obtained from animals or plants
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23B—PRESERVATION OF FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES; CHEMICAL RIPENING OF FRUIT OR VEGETABLES
    • A23B2/00—Preservation of foods or foodstuffs, in general
    • A23B2/70—Preservation of foods or foodstuffs, in general by treatment with chemicals
    • A23B2/725—Preservation of foods or foodstuffs, in general by treatment with chemicals in the form of liquids or solids
    • A23B2/729—Organic compounds; Microorganisms; Enzymes
    • A23B2/771—Organic compounds containing hetero rings
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23B—PRESERVATION OF FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES; CHEMICAL RIPENING OF FRUIT OR VEGETABLES
    • A23B2/00—Preservation of foods or foodstuffs, in general
    • A23B2/70—Preservation of foods or foodstuffs, in general by treatment with chemicals
    • A23B2/725—Preservation of foods or foodstuffs, in general by treatment with chemicals in the form of liquids or solids
    • A23B2/729—Organic compounds; Microorganisms; Enzymes
    • A23B2/783—Microorganisms; Enzymes
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23B—PRESERVATION OF FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES; CHEMICAL RIPENING OF FRUIT OR VEGETABLES
    • A23B4/00—Preservation of meat, sausages, fish or fish products
    • A23B4/10—Coating with a protective layer; Compositions or apparatus therefor
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23B—PRESERVATION OF FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES; CHEMICAL RIPENING OF FRUIT OR VEGETABLES
    • A23B4/00—Preservation of meat, sausages, fish or fish products
    • A23B4/12—Preserving with acids; Acid fermentation
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23B—PRESERVATION OF FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES; CHEMICAL RIPENING OF FRUIT OR VEGETABLES
    • A23B4/00—Preservation of meat, sausages, fish or fish products
    • A23B4/14—Preserving with chemicals not covered by groups A23B4/02 or A23B4/12
    • A23B4/18—Preserving with chemicals not covered by groups A23B4/02 or A23B4/12 in the form of liquids or solids
    • A23B4/20—Organic compounds; Microorganisms; Enzymes
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23B—PRESERVATION OF FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES; CHEMICAL RIPENING OF FRUIT OR VEGETABLES
    • A23B4/00—Preservation of meat, sausages, fish or fish products
    • A23B4/14—Preserving with chemicals not covered by groups A23B4/02 or A23B4/12
    • A23B4/18—Preserving with chemicals not covered by groups A23B4/02 or A23B4/12 in the form of liquids or solids
    • A23B4/20—Organic compounds; Microorganisms; Enzymes
    • A23B4/22—Microorganisms; Enzymes; Antibiotics
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23B—PRESERVATION OF FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES; CHEMICAL RIPENING OF FRUIT OR VEGETABLES
    • A23B5/00—Preservation of eggs or egg products
    • A23B5/06—Coating eggs with a protective layer; Compositions or apparatus therefor
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23B—PRESERVATION OF FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES; CHEMICAL RIPENING OF FRUIT OR VEGETABLES
    • A23B5/00—Preservation of eggs or egg products
    • A23B5/08—Preserving with chemicals
    • A23B5/12—Preserving with chemicals in the form of liquids or solids
    • A23B5/14—Organic compounds; Microorganisms; Enzymes
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23B—PRESERVATION OF FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES; CHEMICAL RIPENING OF FRUIT OR VEGETABLES
    • A23B5/00—Preservation of eggs or egg products
    • A23B5/08—Preserving with chemicals
    • A23B5/12—Preserving with chemicals in the form of liquids or solids
    • A23B5/14—Organic compounds; Microorganisms; Enzymes
    • A23B5/16—Microorganisms; Enzymes
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING OR TREATMENT THEREOF
    • A23C19/00—Cheese; Cheese preparations; Making thereof
    • A23C19/06—Treating cheese curd after whey separation; Products obtained thereby
    • A23C19/068—Particular types of cheese
    • A23C19/08—Process cheese preparations; Making thereof, e.g. melting, emulsifying, sterilizing
    • A23C19/084—Treating the curd, or adding substances thereto, after melting
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L13/00—Meat products; Meat meal; Preparation or treatment thereof
    • A23L13/70—Tenderised or flavoured meat pieces; Macerating or marinating solutions specially adapted therefor
    • A23L13/72—Tenderised or flavoured meat pieces; Macerating or marinating solutions specially adapted therefor using additives, e.g. by injection of solutions
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Preparation or treatment thereof
    • A23L2/52—Adding ingredients
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/127—Antibiotics
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23P—SHAPING OR WORKING OF FOODSTUFFS, NOT FULLY COVERED BY A SINGLE OTHER SUBCLASS
    • A23P10/00—Shaping or working of foodstuffs characterised by the products
    • A23P10/30—Encapsulation of particles, e.g. foodstuff additives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23P—SHAPING OR WORKING OF FOODSTUFFS, NOT FULLY COVERED BY A SINGLE OTHER SUBCLASS
    • A23P10/00—Shaping or working of foodstuffs characterised by the products
    • A23P10/30—Encapsulation of particles, e.g. foodstuff additives
    • A23P10/35—Encapsulation of particles, e.g. foodstuff additives with oils, lipids, monoglycerides or diglycerides
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J13/00—Colloid chemistry, e.g. the production of colloidal materials or their solutions, not otherwise provided for; Making microcapsules or microballoons
    • B01J13/02—Making microcapsules or microballoons
    • B01J13/04—Making microcapsules or microballoons by physical processes, e.g. drying, spraying
    • B01J13/043—Drying and spraying
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J13/00—Colloid chemistry, e.g. the production of colloidal materials or their solutions, not otherwise provided for; Making microcapsules or microballoons
    • B01J13/02—Making microcapsules or microballoons
    • B01J13/06—Making microcapsules or microballoons by phase separation
    • B01J13/08—Simple coacervation, i.e. addition of highly hydrophilic material
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J13/00—Colloid chemistry, e.g. the production of colloidal materials or their solutions, not otherwise provided for; Making microcapsules or microballoons
    • B01J13/02—Making microcapsules or microballoons
    • B01J13/06—Making microcapsules or microballoons by phase separation
    • B01J13/14—Polymerisation; cross-linking
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J13/00—Colloid chemistry, e.g. the production of colloidal materials or their solutions, not otherwise provided for; Making microcapsules or microballoons
    • B01J13/02—Making microcapsules or microballoons
    • B01J13/20—After-treatment of capsule walls, e.g. hardening
    • B01J13/22—Coating
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A40/00—Adaptation technologies in agriculture, forestry, livestock or agroalimentary production
    • Y02A40/90—Adaptation technologies in agriculture, forestry, livestock or agroalimentary production in food processing or handling, e.g. food conservation
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00—Stock material or miscellaneous articles
    • Y10T428/29—Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
    • Y10T428/2982—Particulate matter [e.g., sphere, flake, etc.]
    • Y10T428/2984—Microcapsule with fluid core [includes liposome]

Definitions

  • the present invention relates to a composition that exhibits a microbicidal or microbiostatic action.
  • Bacteriocins are antimicrobial proteins or peptides that can be produced by certain bacteria, which can kill or inhibit the growth of closely related bacteria.
  • the bacteriocins produced by lactic acid bacteria are of particular importance since they have great potential for the preservation of food and for the control of foodborne pathogens. (Wessels et al. 1998.)
  • Nisin The most well known bacteriocin is nisin, which is the only bacteriocin currently authorised as a food additive.
  • Nisin is produced by fermentation of the dairy starter culture bacterium Lactococcus lactis subsp. lactis, and is sold as the commercial extract Nisaplin® Natural Antimicrobial (Danisco).
  • Nisin has an unusually broad antimicrobial spectrum for a bacteriocin, being active against most Gram-positive bacteria (e.g. species of Bacillus, Clostridium, Listeria, lactic acid bacteria). It is not normally effective against Gram-negative bacteria, yeasts or moulds.
  • Nisin is allowed as a food preservative worldwide but its levels of use and approved food applications are strictly regulated, varying from country to country.
  • bacteriocins have since been discovered with potential as food preservatives, e.g. pediocin, lactcin, sakacin, lactococcin, enterococin, plantaricin, leucocin. These are also active, although usually with a more narrow spectrum, against Gram-positive bacteria. Their food use is at present restricted to production of the bacteriocin in situ, i.e. by growth of the producer organism within the food.
  • Antioxidants are widely used in food products susceptible to oxidative degeneration.
  • An antioxidant is defined by the Food and Drug Administration (21 CFR 170.3) as “a substance used to preserve food by retarding deterioration, rancidity, or discoloration due to oxidation”.
  • Spices or plant extracts can be used in food as antioxidants and to impart flavour.
  • One advantage of such extracts is that they are perceived as natural ingredients when compared to chemical antioxidants such as butyl hydroxyanisol (BHA) and butylated hydoxytoluene (BHT). Plants of the family Labiatae contain several well known herbs.
  • Extracts from these plants have been shown to have antioxidant and, in some cases, antimicrobial activity (Nychas & Skandamis, 2003; Smid and Gorris, 1999; Loliger, 1989).
  • Such extracts may be essential oils and oleoresins (extracts with essential oil content used in flavours and fragrances) or “deodorised”, extracts that have a high phenolic diterpene content and low level of flavour-inducing compounds.
  • Carnosic acid a phenolic diterpene (C 20 H 28 O 4 ), occurs naturally in leaves of plants of the Labiatae family, particularly rosemary and sage, but also thyme and marjoram. Dried leaves of rosemary or sage contain 1.5-2.5% carnosic acid and 0.3-0.4% carnosol (US6231896).
  • Carnosol is an oxidative artefact of carnosic acid (Wenkert et al. J. Org. Chem 30:2931, 1965). The oxidation takes place in the presence of harvesting in the leaves left to dry in the air and if the leaves are subjected to extraction with solvents. Rosmanol may also be a product of the oxidation of carnosic acid.
  • WO 98/56395 teaches a mix of tea-tree oil and thyme Essential oil.
  • GB 2275 194 A discusses plant extract disinfectant.
  • US 6083921 discusses a combination of plant extracts including one from Labiatae: Scutellaria, preferably root (Radix scutellariae).
  • U.S. Pat. No. 5,472,684 teaches an oral composition for plaque and gingivitis containing thymol and eugenol
  • Food safety and prevention of food spoilage is an ever present concern worldwide, particularly with the increasing trend for convenience foods such as ready to eat meals, soups, sauces or snacks. Spoilage of food is a major economic problem for the food manufacturer. Food manufacturers need to protect the health and safety of the public by delivering products that are safe to eat. Such food must have a guaranteed shelf life, either at chilled or ambient temperature storage. Consumers prefer good tasting food of high quality—this is difficult to achieve with chemical preservatives, harsh heating regimes and other processing measures. Food safety and protection is best achieved with a multiple preservation system using a combined approach of milder processing and natural preservatives. Foodborne micro-organisms are also less able to adapt and grow in food preserved with different preservative measures.
  • Bacteriocins such as nisin can be used as preservatives in food to help meet this need.
  • Nisin is a proven safe, natural preservative with GRAS status.
  • Other bacteriocins can be used for preservation if produced in situ, by growth of the bacteriocin producer organism in the food.
  • the present invention alleviates the problems of the prior art.
  • the present invention provides a composition
  • a composition comprising (a) an antimicrobial material; and (b) an extract obtained from or obtainable from a plant of the Labiatae family, wherein (a) and (b) are different; wherein the composition contains phenolic diterpenes in an amount of greater than 1.0 wt. %, based on the composition, and wherein when the antimicrobial material consists of nisin, the composition comprises carvacrol in an amount of less than 0.075 wt. % based on the composition and carvone in an amount of less than 15 wt. % based on the composition.
  • the present invention provides a process for preventing and/or inhibiting the growth of, and/or killing a microorganism in a material, the process comprising the step of contacting the material with (a) an antimicrobial material; and (b) an extract obtained from or obtainable from a plant of the Labiatae family, wherein (a) and (b) are different; wherein the composition contains phenolic diterpenes in an amount of greater than 1.0 wt. %, based on the composition, and wherein when the antimicrobial material consists of nisin, the composition comprises carvacrol in an amount of less than 0.075 wt. % based on the composition and carvone in an amount of less than 15 wt. % based on the composition.
  • the present invention provides use of (a) an antimicrobial material; and b) an extract obtained from or obtainable from a plant of the Labiatae family, for preventing and/or inhibiting the growth of, and/or killing a micro-organism in a material; wherein (a) and (b) are different; wherein the composition contains phenolic diterpenes in an amount of greater than 1.0 wt. %, based on the composition, and wherein when the antimicrobial material consists of nisin, the composition comprises carvacrol in an amount of less than 0.075 wt. % based on the composition and carvone in an amount of less than 15 wt. % based on the composition.
  • the present invention provides kit for preparing a composition as defined herein, the kit comprising (a) an antimicrobial material; and (b) an extract obtained from or obtainable from a plant of the Labiatae family, wherein (a) and (b) are different; wherein the composition contains phenolic diterpenes in an amount of greater than 1.0 wt. %, based on the composition, and wherein when the antimicrobial material consists of nisin, the composition comprises carvacrol in an amount of less than 0.075 wt. % based on the composition and carvone in an amount of less than 15 wt. % based on the composition, in separate packages or containers; optionally with instructions for admixture and/or contacting and/or use.
  • rosemary and sage have antioxidant activity in foods that is mainly related to phenolic diterpenes such as carnosic acid and carnosol, as well as other phenolic compounds, including phenolic triterpenes such as betulinic acid, oleanolic add and ursolic acid; and rosmarinic acid.
  • Antimicrobial activity has been attributed to some of these compounds, all of which can be obtained by selective extraction from the plants.
  • the phenolic diterpenes, phenolic triterpenes and rosmarinic acid are distinct from the essential oils and oleoresins that are often used in flavours and fragrances. The high flavour and odour levels of essential oils is not conducive to their use in food.
  • the present invention provides a synergistic combination of components for preventing and/or inhibiting the growth of, and/or killing a micro-organism in a material, such as foodstuff.
  • This combination of components allows lower levels of the antimicrobial material to be used to provide effective action and prevent the development of tolerance to the antimicrobial material. This is particularly important in food applications where reduction of dosage and/or avoidance of development of tolerance is desired for commercial and regulatory reasons.
  • the antimicrobial material is a bacteriocin.
  • the antimicrobial material such as a bacteriocin
  • a bacteriocin may typically be selected from materials (bacteriocins) that can be used as preservatives in food
  • the antimicrobial material is at least nisin.
  • the antimicrobial material consists of nisin.
  • Nisin is a lanthionine-containing bacteriocin (U.S. Pat. No. 5,691,301) derived from Lactococcus lactis subsp. lactis (formerly known as Streptococcus - lactis ) (U.S. Pat. No. 5,573,801).
  • the bacteriocin used in the present invention is at least nisin.
  • nisin is a polypeptide bacteriocin produced by the lactic acid bacteria, Lactococcus lactis subsp. lactis (formerly known as Streptococcus lactis Group N).
  • Nisin is reportedly a collective name representing several closely related substances which have been designated nisin compounds A, B, C, D and E (De Vuyst, L. and Vandamme, E. J. 1994. Nisin, a lantibiotic produced by Lactococcus lactis subsp. lactis: properties, biosynthesis, fermentation and applications. In: Bacteriocins of lactic acid bacteria. Microbiology, Genetics and Applications. Eds.: De Vuyst and Vandamme. Blackie Academic and Professional, London). The structure and properties of nisin are also discussed in the article by E. Lipinska, entitled “Nisin and Its Applications”, The 25th Proceedings of the Easter School in Agriculture Science at the University of Nottingham, 1976, pp.
  • Nisin has the food additive number E234 and is classed as GRAS (Generally Recognised As Safe) (Food and Drug Administration. 1988. Nisin preparation: Affirmation of GRAS status as a direct human ingredient. Federal Regulations 53: 11247).
  • the international activity unit (IU hereinafter) was defined as 0.001 mg of an international nisin reference preparation.
  • Nisaplin® Natural Antimicrobial is the brand name for a nisin concentrate containing 1 million IU per g, which is commercially available from Danisco.
  • Nisin is an acknowledged and accepted food preservative with a long history of safe, effective food use. There have been several reviews of nisin, e.g. Hurst 1981; 1983; Delves-Broughton, 1990; De Vuyst and Vandamme, 1994; Thomas et al. 2000; Thomas & Delves-Broughton, 2001). Nisin was discovered over 50 years ago and the first commercial preparation, made in 1953, was Nisaplin®. Nisin has several characteristics that make it particularly suitable as a food preservative. It has undergone extensive toxicological testing to demonstrate its safety. It is heat-stable, acid-stable and effective against a broad spectrum of Gram-positive bacteria.
  • Nisin is an effective preservative in pasteurised and heat-treated foods (e.g.
  • processed cheese, cheese, pasteurised milks, dairy desserts, cream, mascarpone and other dairy products puddings such as semolina, tapioca etc., pasteurised liquid egg, pasteurised potato products, soy products, crumpets, pikelets, flapjacks, processed meat products, beverages, soups, sauces, ready to eat meals, canned foods, vegetable drinks) and low acid foods such as salad dressings, sauces, mayonnaise, beer, wine and other beverages.
  • bacteriocin pediocin produced by Pediococcus pentosaceus, P. acidilactici, or Lactobacillus plantarum, may be used in the present invention. Like nisin, different structures of pediocin have been described.
  • pediocin and other bacteriocins are not allowed as food additives but their antibacterial activity can be achieved by production of the bacteriocin in situ, as a consequence of the growth of the producer organism in the food. This is the purpose of commercial s protective cultures such as HOLDBACTM Listeria (Danisco).
  • Pediocin has a more narrow antimicrobial spectrum compared to nisin, but there is much interest in its food safety ability to kill, prevent or control the growth of the food pathogen Listeria monocytogenes (Ray & Miller, 2000).
  • bacteriocins may be used in the present invention, including those named generally as divercin, leucocin, mesentericin, sakacin, curvacin, bavaricin, acidocin, bifidocin, carnobacteriocin, pisicocin, piscicolin, mundticin, enterocin, thermophilin, lacticin, plantaricin, lactococcin, divercin, diplococcin, mesenterocin, leuconosin, camosin, acidophilin, lactacin, brevicin, lactocin, helevticin, reutericin, propionicin.
  • the composition comprises carvacrol in an amount of less than 0.075 wt. % based on the composition and carvone in an amount of less than 15 wt. % based on the composition.
  • the composition comprises carvacrol in an amount of less than 0.05 wt. % based on the composition, preferably less than 0.04 wt. %, preferably less than 0.02 wt. %, preferably less than 0.01 wt. %, preferably less than 0.004 wt. %, based on the composition.
  • the composition comprises carvacrol in an amount of less than 0.05 wt. % based on the composition, preferably less than 0.04 wt. %, preferably less than 0.02 wt. %, preferably less than 0.01 wt. %, preferably less than 0.004 wt. %, based on the composition.
  • the composition comprises carvone in an amount of less than 10 wt. % based on the composition, preferably less than 7 wt. %, preferably less than 5 wt. %, preferably less than 2 wt. %, preferably less than 1 wt. %, preferably less than 0.75 wt. %, preferably less than 0.5 wt. %, preferably less than 0.2 wt. %, preferably less than 0.1 wt. %, preferably less than 0.075 wt. %, preferably less than 0.05 wt. %, preferably less than 0.04 wt. %, preferably less than 0.02 wt. %, preferably less than 0.01 wt. %, preferably less than 0.004 wt. %, based on the composition.
  • the composition comprises carvone in an amount of less than 10 wt. % based on the composition, preferably less than 7 wt. %, preferably less than 5 wt. %, preferably less than 2 wt. %, preferably less than 1 wt. %, preferably less than 0.75 wt. %, preferably less than 0.5 wt. %, preferably less than 0.2 wt. %, preferably less than 0.1 wt. %, preferably less than 0.75 wt. %, preferably less than 0.05 wt. %, preferably less than 0.04 wt. %, preferably less than 0.02 wt. %, preferably less than 0.01 wt. %, preferably less than 0.004 wt. %, based on the composition.
  • the composition comprises thymol in an amount of less than 1 5 wt. % based on the composition, preferably less than 10 wt. %, preferably less than 7 wt. %, preferably less than 5 wt. %, preferably less than 2 wt. %, preferably less than 1 wt. %, preferably less than 0.75 wt. %, preferably less than 0.5 wt. %, preferably less than 0.2 wt. %, preferably less than 0.1 wt. %, preferably less than 0.075 wt. %, preferably less than 0.05 wt. %, preferably less than 0.04 wt. %, preferably less than 0.02 wt. %, preferably less than 0.01 wt. %, preferably less than 0.004 wt. %, based on the composition.
  • the composition comprises thymol in an amount of less than 15 wt. % based on the composition preferably less than 10 wt. %, preferably less than 7 wt. %, preferably less than 5 wt. %, preferably less than 2 wt. %, preferably less than 1 wt. %, preferably less than 0.75 wt. %, preferably less than 0.5 wt. %, preferably less than 0.2 wt. %, preferably less than 0.1 wt. %, preferably less than 0.075 wt. %, preferably less than 0.05 wt. %, preferably less than 0.04 wt. %, preferably less than 0.02 wt. %, preferably less than 0.01 wt. %, preferably less than 0.004 wt. %, preferably less than 0.004 wt. %, based on the composition.
  • the composition comprises eugenol in an amount of less than 15 wt. % based on the composition, preferably less than 10 wt. %, preferably less than 7 wt. %, preferably less than 5 wt. %, preferably less than 2 wt. %, preferably less than 1 wt. %, preferably less than 0.75 wt. %, preferably less than 0.5 wt. %, preferably less than 0.2 wt. %, preferably less than 0.1 wt. %, preferably less than 0.075 wt. %, preferably less than 0.05 wt. %, preferably less than 0.04 wt. %, preferably less than 0.02 wt. %, preferably less than 0.01 wt. %, preferably less than 0.004 wt. %, based on the composition.
  • the composition comprises eugenol in an amount of less than 15 wt. % based on the composition preferably less than 10 wt. %, preferably less than 7 wt. %, preferably less than 5 wt. %, preferably less than 2 wt. %, preferably less than 1 wt. %, preferably less than 0.75 wt. %, preferably less than 0.5 wt. %, preferably less than 0.2 wt. %, preferably less than 0.1 wt. %, preferably less than 0.075 wt. %, preferably less than 0.05 wt. %, preferably less than 0.04 wt. %, preferably less than 0.02 wt. %, preferably less than 0.01 wt. %, preferably less than 0.004 wt. %, based on the composition.
  • the composition comprises carvacrol in an amount of less than 0.075 wt. % based on the composition and each of carvone and thymol in amounts of less than 15 wt. % based on the composition (preferably less than 10 wt. % based on the composition, preferably less than 7 wt. %, preferably less than 5 wt. %, preferably less than 2 wt. %, preferably less than 1 wt. %, preferably less than 0.75 wt. %, preferably less than 0.5 wt. %, preferably less than 0.2 wt. %, preferably less than 0.1 wt.
  • % preferably less than 0.075 wt. %, preferably less than 0.05 wt. %, preferably less than 0.04 wt. %, preferably less than 0.02 wt. %, preferably less than 0.01 wt. %, preferably less than 0.004 wt. %, based on the composition).
  • the composition comprises carvacrol in an amount of less than 0.075 wt. % based on the composition and each of carvone and thymol in amounts of less than 15 wt. % based on the composition (preferably less than 10 wt. % based on the composition, preferably less than 7 wt. %, preferably less than 5 wt. %, preferably less than 2 wt. %, preferably less than 1 wt. %, preferably less than 0.75 wt. %, preferably less than 0.5 wt. %, preferably less than 0.2 wt. %, preferably less than O.1 wt. %, preferably less than 0.075 wt.
  • % preferably less than 0.05 wt. %, preferably less than 0.04 wt. %, preferably less than 0.02 wt. %, preferably less than 0.01 wt. %, preferably less than 0.004 wt. %, based on the composition).
  • the composition comprises carvacrol in an amount of less than 0.075 wt. % based on the composition and each of carvone, thymol and eugenol in amounts of less than 15 wt. % based on the composition (preferably less than 10 wt. % based on the composition, preferably less than 7 wt. %, preferably less than 5 wt. %, preferably less than 2 wt. %, preferably less than 1 wt. %, preferably less than 0.75 wt. %, preferably less than 0.5 wt. %, preferably less than 0.2 wt.
  • % preferably less than 0.1 wt. %, preferably less than 0.075 wt. %, preferably less than 0.05 wt. %, preferably less than 0.04 wt. %, preferably less than 0.02 wt. %, preferably less than 0.01 wt. %, preferably less than 0.004 wt. %, based on the composition).
  • the composition comprises carvacrol in an amount of less than 0.075 wt. % based on the composition and each of carvone, thymol and eugenol in amounts of less than 15 wt. % based on the composition (preferably less than 10 wt. % based on the composition, preferably less than 7 wt. %, preferably less than 5 wt. %, preferably less than 2 wt. %, preferably less than 1 wt. %, preferably less than 0.75 wt. %, preferably less than 0.5 wt. %, preferably less than 0.2 wt. %, preferably less than 0.1 wt.
  • % preferably less than 0.075 wt. %, preferably less than 0.05 wt. %, preferably less than 0.04 wt. %, preferably less than 0.02 wt. %, preferably less than 0.01 wt. %, preferably less than 0.004 wt. %, based on the composition).
  • the composition comprises each of carvacrol and carvone in an amount of less than 1 wt. % based on the extract.
  • the composition comprises each of carvacrol and carvone in an amount of less than 0.075 wt. %, preferably less than 0.05 wt. %, preferably less than 0.04 wt. %, preferably less than 0.02 wt. %, preferably less than 0.01 wt. %, preferably less than 0.004 wt. %, based on the extract.
  • the composition comprises each of carvacrol, carvone and thymol in amounts of less than 1 wt. % based on the extract.
  • the composition comprises each of carvacrol, carvone and thymol in an amount of less than 0.075 wt. %, preferably less than 0.05 wt. %, preferably less than 0.04 wt. %, preferably less than 0.02 wt. %, preferably less than 0.01 wt. %, preferably less than 0.004 wt. %, based on the extract.
  • the composition comprises each of carvacrol, carvone, thymol and eugenol in amounts of less than 1 wt. % based on the extract.
  • the composition comprises each of carvacrol, carvone, thymol and eugenol in an amount of less than 0.075 wt. %, preferably less than 0.05 wt. %, preferably less than 0.04 wt. %, preferably less than 0.02 wt. %, preferably less than 0.01 wt. %, preferably less than 0.004 wt. %, based on the extract.
  • the composition comprises each of carvacrol and carvone in an amount of less than 1 wt. % based on the extract.
  • the composition comprises each of carvacrol and carvone in an amount of less than 0.075 wt. %, preferably less than 0.05 wt. %, preferably less than 0.04 wt. %, preferably less than 0.02 wt. %, preferably less than 0.01 wt. %, preferably less than 0.004 wt. %, based on the extract.
  • the composition comprises each of carvacrol, carvone and thymol in amounts of less than 1 wt. % based on the extract.
  • the composition comprises each of carvacrol, carvone and thymol in an amount of less than 0.075 wt. %, preferably less than 0.05 wt. %, preferably less than 0.04 wt. %, preferably less than 0.02 wt. %, preferably less than 0.01 wt. %, preferably less than 0.004 wt. %, based on the extract.
  • the composition comprises each of carvacrol, carvone, thymol and eugenol in amounts of less than 1 wt. % based on the extract.
  • the composition comprises each of carvacrol, carvone, thymol and eugenol in an amount of less than 0.075 wt. %, preferably less than 0.05 wt. %, preferably less than 0.04 wt. %, preferably less than 0.02 wt. %, preferably less than 0.01 wt. %, preferably less than 0.004 wt. %, based on the extract.
  • the extract used in the present invention is obtained from or is obtainable from a plant of the Labiatae family.
  • the extract used in the present invention is obtained from a plant of the Labiatae family.
  • the extract used in the present invention is obtainable from a plant of the Labiatae family.
  • an extract obtainable from a plant may be obtained from a plant or may be isolated from the plant, identified and then obtained from an alternative source, for example by chemical synthesis or enzymatic production.
  • the extract may be produced by a eukaryotic or prokaryotic fermentation, by a process of genetic manipulation.
  • the present applicant have recognised that products present in a plant of the Labiatae family may synergistically increase the activity of a an antimicrobial material, preferably a bacteriocin. These products may be obtained from any source and will fall within the scope of the present invention.
  • the invention comprises use of a combination of a bacteriocin such as nisin and a of the Labiatae plant family, such as rosemary ( Rosmarinus officinalls ) or sage ( Salvia officinalis ) that together give enhanced control of Gram-positive bacteria in a food system.
  • the extracts responsible for synergy in the present invention preferably refer to extracts of the plant family Labiatae that have been selectively extracted (“deodorised extracts”) to increase their phenolic diterpene content (such as carnosol and carnosic acid), phenolic tripterpene content (such as ursolic acid, betulinic acid and oleanolic acid) or rosmarinic acid content.
  • deodorised extracts can be distinguished by their high phenolic diterpene content (for example greater than 3.5 wt. %) and their low level (less than 1 wt. %) of flavour-inducing compounds from plant essential oils and oleoresins that are used as flavours or fragrances.
  • Essential oils are typically extracted by simple steam distillation of the plant material.
  • Essential oils comprise the various essential oils in plants having the odour or the flavour of the plant from which they were extracted.
  • the essential oils are typically terpenoids often comprising monoterpenes.
  • an antioxidant type of rosemary extract which could be described as selectively extracted or deodorised, contains >3.5% phenolic diterpenes but less than 1 wt. % essential oils.
  • a non-selective, flavouring extract contains 10-30 wt. % essential oils and a phenolic diterpene content of 2->3.5 wt. %.
  • Essential oils are commonly described as the volatile ethereal fraction obtained from a plant or plant part by a physical separation process such as distillation or chromatographic separation.
  • Essential oils have also been described as a “group of odorous principles, soluble in alcohol and to a limited extent in water, consisting of a mixtures of esters, aldehydes, ketones and terpenes.
  • Essential oils are typically obtained by distilling plants with water; the oil that separates from distillate usually has highly characteristic odors identified with the plant origin. The resulting mixture of organic compounds was thought, in the days of alchemists, to be the essence of the plant, hence the term “essential oil”.
  • the extract is a deodorised extract.
  • the (deodorised) extract contains from 1.0 to 70 wt. % phenolic diterpenes, preferably 3.5 to 70 wt. % phenolic diterpenes and less than 1 wt. % essential oil.
  • the extract is selected from phenolic diterpenes, phenolic triterpenes and rosmarinic acid.
  • the extract is or comprises a phenolic diterpene.
  • the phenolic diterpene is selected from carnosic acid, carnosol and methylcarnosic acid.
  • the phenolic diterpene is selected from carnosic acid and carnosol.
  • the combined amount of phenolic diterpenes, and phenolic triterpenes and rosmarinic acid, based on the extract is greater than 1.0 wt. %. In one preferred aspect the combined amount of phenolic diterpenes, and phenolic triterpenes and rosmarinic acid, based on the composition, is greater than 1.0 wt. %.
  • the combined amount of phenolic diterpenes, and phenolic triterpenes and rosmarinic acid, based on the extract is greater than 3.5 wt. %. In one preferred aspect the combined amount of phenolic diterpenes, and phenolic triterpenes and rosmarinic acid, based on the composition, is greater than 3.5 wt. %.
  • the amount of phenolic diterpenes, based on the extract is greater than 1.0 wt. %, for example greater than 5.0 wt. %, greater than 10.0 wt. %, greater than 20.0 wt. %, or greater than 25.0 wt. %. In one preferred aspect the amount of phenolic diterpenes, based on the composition, is greater than 1.0 wt. %.
  • the amount of phenolic diterpenes, based on the extract is greater than 3.5 wt. %. In one preferred aspect the amount of phenolic diterpenes, based on the composition, is greater than 3.5 wt. %.
  • the amount of phenolic diterpenes, based on the composition is greater than 1.0 wt. %, preferably greater than 2.0 wt. %, preferably greater than 3.0 wt. %, preferably greater than 3.5 wt. %, preferably greater than 5.0 wt. %, preferably greater than 10.0 wt. %, preferably greater than 20.0 wt. %, preferably greater than 40.0 wt. %, preferably greater than 50.0 wt. %.
  • the amount of phenolic diterpenes, based on the composition is from 2.0 to 2.5 wt. %, such as 2.3 wt. %.
  • the amount of phenolic diterpenes, based on the composition is from 4.0 to 4.5 wt. %, such as 4.2 wt. %.
  • the amount of phenolic diterpenes, based on the extract is greater than 1.0 wt. %, preferably greater than 2.0 wt. %, preferably greater than 3.0 wt. %, preferably greater than 3.5 wt. %, preferably greater than 5.0 wt. %, preferably greater than 10.0 wt. %, preferably greater than 20.0 wt. %, preferably greater than 40.0 wt. %, preferably greater than 50.0 wt. %.
  • the extract contains one or more phenolic triterpenes.
  • the phenolic triterpenes are selected from betulinic acid, oleanolic acid, and ursolic acid.
  • phenolic triterpene is selected from betulinic acid, oleanolic acid, and ursolic acid.
  • the amount of phenolic triterpenes, based on the extract is greater than 3.5 wt. %. In one highly preferred aspect the amount of phenolic triterpenes, based on the composition, is greater than 3.5 wt. %.
  • the extract is or comprises rosmarinic acid.
  • the amount of rosmarinic acid, based on the extract is greater than 3.5 wt. %. In one preferred aspect the amount of rosmarinic acid, based on the composition, is greater than 3.5 wt. %.
  • the extract contains flavour-inducing compounds and/or essential oils in an amount of less than 1 wt. % based on the extract. In one preferred aspect the extract contains flavour-inducing compounds and/or essential oils in an amount of less than 1 wt. % based on the composition.
  • flavour-inducing compounds and/or essential oils are camphor, verbenone, borneol and alfa-terpineol.
  • the combined amount of camphor present in the extract is less than 1 wt. % (preferably less than 0.2 wt. %, more preferably less than 0.15 wt. %, more preferably less than 0.1 wt. %) based on the extract.
  • the combined amount of borneol present in the extract is less than 1 wt. % (preferably less than 0.2 wt. %, more preferably less than 0.15 wt. %, more preferably less than 0.1 wt. %) based on the extract.
  • the combined amount of alfa-terpineol present in the extract is less than 1 wt. % (preferably less than 0.2 wt. %, more preferably less than 0.15 wt. %, more preferably less than 0.1 wt. %) based on the extract.
  • the combined amount of camphor, verbenone, borneol and alfa-terpineol present in the extract is less than 1 wt. % (preferably less than 0.2 wt. %, more preferably less than 0.15 wt. %, more preferably less than 0.1 wt. %) based on the extract.
  • the extract contain less than 1 wt. % of plant essential oils and/or oleoresins based on the extract. In one preferred aspect the extract contain less than 1 wt. % of plant essential oils and/or oleoresins based on the composition.
  • the extract contains essential oils in an amount of less than 1 wt. % based on the extract. In one preferred aspect the extract contains essential oils in an amount of less than 1 wt. % based on the composition.
  • the plant of the Labiatae family is selected from rosemary, sage, oregano, marjoram, mint, balm, savoury and thyme. In one preferred aspect the plant of the Labiatae family is selected from rosemary, sage, oregano, marjoram, mint, balm, and savoury. It will be understood that these name cover all species and varieties of plants known by these names.
  • the plant of the Labiatae family is selected from rosemary ( Rosmarinus officinalis L.), sage ( Salvia officinalis L.) oregano ( Origanum vulgare L.), marjoram ( Origanum marjorana L.), mint ( Mentha spp.), balm ( Melissa officinalis L.), savoury ( Satureia hortensis ), thyme ( Thymus vulgaris L.).
  • the plant of the Labiatae family is selected from rosemary ( Rosmarinus officinalis L.), sage ( Salvia officinalis L.), oregano ( Origanum vulgare L.), marjoram ( Origanum mailorana L.), mint ( Mentha spp.), balm ( Melissa officinalis L.), and savoury ( Satureia hortensis ).
  • the plant of the Labiatae family is selected from rosemary ( Rosmarinus officinalis L.), sage ( Salvia officinalis L.), marjoram ( Origanum marjorana L.), mint ( Mentha spp.), balm ( Melissa officinalis L.), and savoury ( Satureia hortensis ).
  • the plant of the Labiatae family is rosemary.
  • phenolic diterpenes, phenolic triterpenes and rosmarinic acid are obtained by chemical synthesis.
  • the present invention provides
  • the present invention may prevent and/or inhibit the growth of, and/or kill a micro-organism in a material. This may be slowing or arresting a micro-organism, such a bacteria, or by killing the micro-organism present on contact with the present composition.
  • the antimicrobial material and/or the extract are present in an amount to provide a microbicidal or microbiostatic effect.
  • the bacteriocin and the extract are present in an amount to provide a microbicidal or microbiostatic effect.
  • the bacteriocin and the extract are present in an amount to provide a microbicidal or microbiostatic synergistic effect.
  • the bacteriocin and the extract are present in an amount to provide a microbicidal synergistic effect.
  • microbicidal or microbiostatic effect is a bactericidal or bacteriostatic effect.
  • the bactericidal or bacteriostatic effect is advantageous for the bactericidal or bacteriostatic effect to be in respect of Gram-positive bacteria and Gram-negative bacteria.
  • the bactericidal or bacteriostatic effect is in respect of Gram-positive bacteria.
  • the bactericidal or bacteriostatic effect is in respect of an organism selected from Gram-positive bacteria associated with food spoilage or foodborne disease including Bacillus species, Bacillus subtilis, Bacillus cereus, Listeria species, Listeria monocytogenes, lactic acid bacteria, lactic acid spoilage bacteria, Lactobacillus species, Staphylococcus aureus, Clostridium species, C. sporogenes, C. tyrobutyricum.
  • the bactericidal or bacteriostatic effect of the invention in combination with a chelating agent is in respect of an organism selected from other micro-organisms associated with food spoilage or foodborne disease, including yeasts, moulds and Gram-negative bacteria including Escherichia coli, Salmonella species, and Pseudomonas species.
  • the bactericidal or bacteriostatic effect is in respect of Listeria monocytogenes.
  • compositions, process and use of the present invention may prevent and/or inhibit the growth of, and/or kill a micro-organism in any material.
  • the composition is a foodstuff or may be added to a foodstuff.
  • the essential components of (a) an antimicrobial material and (b) a extract obtained from or obtainable from a plant of the Labiatae family are already present in the foodstuff. They may have been provided by one or more means. For example they may have been added in the form of a composition containing the bacteriocin and the extract.
  • the two components may have been added to the foodstuff sequentially.
  • one or more of the components may have be formed in situ in the foodstuff.
  • the bacteriocin may be formed in situ in the foodstuff by fermentation of the dairy starter culture bacterium Lactococcus lactis subsp. lactis.
  • composition of the present invention is a protectant composition suitable for addition to a foodstuff.
  • Typical foodstuffs are raw meat, cooked meat, raw poultry products, cooked poultry products, raw seafood products, cooked seafood products, ready to eat meals, pasta sauces, pasteurised soups, mayonnaise, salad dressings, oil-in-water emulsions, margarines, low fat spreads, water-in-oil emulsions, dairy products, cheese spreads, processed cheese, dairy desserts, flavoured milks, cream, fermented milk products, cheese, butter, condensed milk products, ice cream mixes, soya products, pasteurised liquid egg, bakery products, confectionery products, fruit products, and foods with fat-based or water-containing fillings.
  • the compositon of the present invention or the composition for use in the present invention may contain one or more additional components.
  • the protectant composition of the present invention (suitable for addition to a foodstuff) contains no additional components or contains no additional components that materially affect the properties of the composition.
  • the present invention provides
  • the composition further comprises an emulsifier.
  • the emulsifier is selected from polyoxy-ethylene sorbitan esters (E432-E436) otherwise known as polysorbates (e.g. Tween 80, Tween 20), monoglycerides, diglycerides, acetic acid esters of mono-diglycerides, tartaric acid esters of mono-diglycerides and citric acid esters of mono-diglycerides.
  • composition further comprises a chelator.
  • a chelator is selected from EDTA, citric acid, monophosphates, diphosphates, triphosphates and polyphosphates.
  • sequestering agents are useful in food processing in their salt forms, which are commonly alkali metal or alkaline earth salts such as sodium, potassium or calcium or quaternary ammonium salts. Sequestering compounds with multiple valencies may be beneficially utilised to adjust pH or selectively introduce or abstract metal ions e.g. in a food system coating. Additional information chelators is disclosed in T. E. Furia (Ed.), CRC Handbook of Food Additives, 2nd Ed., pp. 271-294 (1972, Chemical Rubber Co.), and M. S. Peterson and A. M. Johnson (Eds.), Encyclopaedia of Food Science, pp. 694-699 (1978, AVI Publishing Company, Inc.) which articles are both hereby incorporated by reference.
  • chelator is defined as organic or inorganic compounds capable of forming co-ordination complexes with metals. Also, as the term “chelator” is used herein, it includes molecular encapsulating compounds such as cyclodextrin. The chelator may be inorganic or organic, but preferably is organic.
  • Preferred chelator are non-toxic to mammals and include aminopolycarboxylic acids and their salts such as ethylenediaminetetraacetic acid (EDTA) or its salts (particularly its di- and tri-sodium salts), and hydrocarboxylic acids and their salts such as citric acid.
  • aminopolycarboxylic acids and their salts such as ethylenediaminetetraacetic acid (EDTA) or its salts (particularly its di- and tri-sodium salts), and hydrocarboxylic acids and their salts such as citric acid.
  • EDTA ethylenediaminetetraacetic acid
  • hydrocarboxylic acids and their salts such as citric acid.
  • non-citric acid and non-citrate hydrocarboxylic acid chelators are also believed useful in the present invention such as acetic acid, formic acid, lactic acid, tartaric acid and their salts.
  • chelator is defined and used herein as a synonym for sequestering agent and is also defined as including molecular encapsulating compounds such as cyclodextrin.
  • Cyclodextrins are cyclic carbohydrate molecules having six, seven, or eight glucose monomers arranged in a donut shaped ring, which are denoted alpha, beta or gamma cyclodextrin, respectively.
  • cyclodextrin refers to both unmodified and modified cyclodextrin monomers and polymers. Cyclodextrin molecular encapsulators are commercially available from American Maize-Products of Hammond, Ind.
  • Cyclodextrin are further described in Chapter 11 entitled, “Industrial Applications of Cyclodextrin”, by J. Szejtli, page 331-390 of Inclusion Compounds, Vol. III (Academic Press, 1984) which chapter is hereby incorporated by reference.
  • the chelator enhances the antimicrobial activity and/or antimicrobial spectrum of the bacteriocin. More preferably the chelator enhances the antimicrobial activity and/or antimicrobial spectrum of the bacteriocin in respect of Gram-negative bacteria and other micro-organisms.
  • composition further comprises a lytic enzyme.
  • lytic enzyme is a lysozyme.
  • the present invention provides process for preventing and/or inhibiting the growth of, and/or killing a micro-organism in a material, the process comprising the step of contacting the material with (a) an antimicrobial material; and (b) an extract obtained from or obtainable from a plant of the Labiatae family, wherein (a) and (b) are different; wherein the composition contains phenolic diterpenes in an amount of greater than 1.0 wt. %, based on the composition, and wherein when the antimicrobial material consists of nisin, the composition comprises carvacrol in an amount of less than 0.075 wt. % based on the composition and carvone in an amount of less than 15 wt. % based on the composition.
  • the bacteriocin and the extract are added to the material together.
  • the bacteriocin and the extract are added to the material sequentially.
  • the present invention provides in one aspect a preservative/protectant composition which may be added to a range of materials such as food systems and in another aspect a combination of two separate products which may added sequentially to materials such as food products.
  • the extract is added to the material.
  • the bacteriocin is added to the material.
  • the extract is formed in situ in the material.
  • the bacteriocin is formed in situ in the material.
  • the bacteriocin may be formed in situ in the foodstuff by fermentation of the dairy starter culture bacterium Lactococcus lactis subsp. lactis.
  • the present invention provides a process for preventing and/or inhibiting the growth of, and/or killing a micro-organism in a material, the process comprising the step of contacting the material with (a) an antimicrobial material; and (b) an extract obtained from or obtainable from a plant of the Labiatae family, wherein (a) and (b) are different; wherein when the antimicrobial material consists of nisin, the composition comprises carvacrol in an amount of less than 0.075 wt. % based on the composition and carvone in an amount of less than 15 wt. % based on the composition.
  • the present invention provides use of (a) an antimicrobial material; and b) an extract obtained from or obtainable from a plant of the Labiatae family, for preventing and/or inhibiting the growth of, and/or killing a micro-organism in a material; wherein (a) and (b) are different; and wherein when the antimicrobial material consists of nisin, the composition comprises carvacrol in an amount of less than 0.075 wt. % based on the composition and carvone in an amount of less than 15 wt. % based on the composition.
  • FIG. 1 is a graph showing synergistic enhancement of nisin cidal activity against Listeria monocytogenes in chicken soup at 25° C. by a selectively extracted rosemary extract
  • FIG. 2 is a graph showing synergistic enhancement of nisin control of Listeria monocytogenes growth in chilled chicken soup by a selectively extracted rosemary extract (GRE09)
  • FIG. 3 is a graph showing synergistic enhancement by a selectively extracted rosemary extract of nisin control of B. cereus spore outgrowth in chilled chicken soup. Minimal detection limit was 100 cfu/g. For the length of the testing period, the samples containing the combination of nisin and rosemary had Bacillus counts at or below 100 cfu/g.
  • FIG. 4 is a graph showing combined effect of nisin, selectively extracted rosemary extracts and rosemary extract components against L. monocytogenes in chicken soup at 20° C. (Minimum detection limit 100 cfu/g)
  • FIG. 5 is a graph showing synergistic enhancement of nisin activity by selectively extracted extracts of rosemary or rosmarinic acid against Listeria monocytogenes in a chicken soup at ambient temperature.
  • FIG. 6 is a graph showing a demonstration of synergy between nisin and phenolic diterpene-containing rosemary extract. Inhibition of L. monocytogenes at 8° C.
  • FIG. 7 is a graph showing a demonstration of synergy between nisin and phenolic diterpene-containing rosemary extract. Inhibition of B. cereus at 15° C.
  • FIG. 8 is a graph showing enhanced nisin growth inhibitory activity by a phenolic diterpene-containing rosemary extract. Control of L. monocytogenes in carbonara sauce at 8° C.
  • FIG. 9 is a graph showing enhanced nisin growth inhibitory activity by a phenolic diterpene-containing rosemary extract. Control of B. cereus spores in carbonara sauce at 15° C.
  • FIG. 10 is a graph showing enhanced cidal effect of a nisin and phenolic diterpene-containing rosemary extract against L. monocytogenes in chicken soup at 20° C. a) pH 4.5
  • FIG. 11 is a graph showing enhanced cidal effect of a nisin and phenolic diterpene-containing rosemary extract against L. monocytogenes in chicken soup at 20° C. b) pH 6.7
  • GUARDIANTM Rosemary Extract 09 (Danisco) (GRE09). This is a water dispersible deodorised rosemary extract containing 4% phenolic diterpenes and ⁇ 1% essential oils, extracted from rosemary leaves, combined with the carriers polyoxyethylene sorbitan monooleate (Tween 80) and propylene glycol. A commercial extract of nisin at potency of 1 ⁇ 10 6 IU/g: Nisaplin® Natural Antimicrobial (Danisco).
  • Test strains Bacillus cereus 204, B. cereus Campden, B. cereus NCTC2599, B. subtilis Campden, Listeria monocytogenes 272, L. monocytogenes NCTC12426, L. monocytogenes S23, Lactobacillus sake 272, Escherichia coli S15, E. coli CRA109, Salmonella Typhimurium S29, Pseudomonas fluorescens 3756.
  • a 100,000 ppm GRE09 solution was prepared in water and filter sterilised (0.2 ⁇ m). Further dilutions were prepared in sterile deionised water at 1,250-20,000 ppm.
  • Brain Heart Infusion broth (Oxoid) was prepared and GRE09 stock solutions were added to give the following test solutions of GRE09; 125, 250, 500, 750, 1000, 1250, 1500, 2000 ppm.
  • a 10,000 IU/ml nisin solution was prepared, filter sterilised and a range of stock solutions then prepared. A range of nisin concentrations was then prepared in Brain Heart Infusion broth.
  • a fully automated microbial growth analyser was used to determine microbial growth curves (Microbiology Reader Bioscreen C analyser linked to a PC with installed software BioLink v 5.30; Labsystem Oy, Finland). Tests were prepared in honeycomb 2 (HC 2) microtitre/cuvette plates with a capacity of 100 wells per plate. The wells were loaded with 270 ⁇ l of the prepared media and inoculated at a level of 10 3 CFU (colony forming units)/ml with 30 ⁇ l of microbial suspension. Incubation time and temperature was as appropriate for the test organism. This test allowed suitable test levels for the compounds to be determined. The rosemary extract and nisin were then tested in combination, using the same procedure. Nisin solutions were prepared at 50-1000 IU/ml in broth as above. GRE09 solutions were prepared at 250, 500 and 1000 ppm as above. Combinations of all these test levels were prepared and tested in the Bioscreen as before.
  • Test compounds GRE09 at 0.1%, 0.5%, Nisaplin® (Danisco).
  • Test strains a cocktail was prepared of L. monocytogenes strains NCTC12426, NCTC5105, NCC FSM60 and CRA3930. The Listeria strains were grown at 30° C. on Brain heart infusion agar overnight then inoculated into broth at 30° C. overnight. A volume of each broth was mixed together to give a cocktail of strains with a cell concentration of approximately 10 9 CFU/ml.
  • a chilled pasteurised chicken soup was used as a food model because it was a 15 good mix of different food components including vegetables, dairy products and poultry meat It was comprised of a chicken stock with the addition of chicken, cream, vegetables, flour and seasonings.
  • the pH was 6.12.
  • the soup was pasteurised at a core temperature of 80° C. for 2 minutes.
  • the Listeria cocktail was diluted to 10 4 CFU/ml and inoculated into soup tests to give a final cell count of approximately 10 2 CFU/g (growth inhibitory tests) and 10 7 CFU/ml (cidal tests).
  • the latter test was incubated at 25° C. for 2 h and then tested by viable count enumeration to estimate the extent of cidal activity.
  • the growth test was incubated at 8° C. with regular sampling to estimate bacteriostatic activity.
  • Nisaplin (100 IU/ml) +GRE09 at 0.5%, (b) Nisaplin (250 IU/ml)+GRE09 at 0.1%, and (c) Nisaplin (250 IU/ml)+GRE09 at 0.5% did not give any total aerobic viable counts above 100 cfu/g.
  • Test strains a cocktail of Bacillus spores was prepared as an inoculum, using Bacillus cereus strain 204, Bacillus cereus strain 199, B. cereus strain Campden, and B. cereus strain ABC 4/9.
  • test compounds were made to chicken soup, prepared as above.
  • the soup was pasteurised at 70° C. for 2 minutes, cooled and inoculated with approximately 10 3 CFU/g of a cocktail of Bacillus cereus spores. Incubation was for 56 days. Results are shown in FIG. 3 and summarised in Table 3. Bacteriostatic synergy between the nisin and rosemary extract GRE09 was evident. For example, spoilage (i.e. 10 6 CFU/ml) resulted after 13 days in the presence of 25 IU/ml nisin, and after 10 days in the presence of 300 ppm GRE09. In the presence of both these ingredients, no spoilage had occurred by the end of the trial (56 days).
  • Test strains a cocktail of Clostridium spores was prepared as an inoculum, using Clostridium sporogenes strain Campden, Clostridium sporogenes 1.221, and Clostridium sporogenes NCIMB1793.
  • test compounds were made to chicken soup, prepared as above.
  • the soup was pasteurised at 70° C. for 2 minutes and transferred to sterile test tubes. These were inoculated with a cocktail of heat-shocked Clostridium sporogenes spores, at a level of 2.2 ⁇ 10 2 CFU/g, then anaerobic conditions were created by plugging the tubes with agar.
  • the samples were incubated at 37° C. and checked daily for gas production (observed by blowing of the gas plug and by the distinctive clostridial odour). Results for a 27 day incubation period, demonstrating synergy, are shown in Table 4.
  • MIC Minimal inhibitory concentrations
  • the test compounds comprised nisin (as Nisaplin®; Danisco), GRE09 (Danisco), pure rosmarinic acid (RA; Sigma) and a range of deodorised rosemary extracts. These had been prepared by selected extraction with either organic solvents or CO 2 to obtain extracts containing 28% phenolic diterpenes (28RE; Danisco) and a rosemary extract containing 6% rosmarinic acid (6RA; Danisco).
  • nisin activity was evident with a combination of nisin combined with pure rosmarinic acid (RA; this may have partly been due to low pH levels), a combination of nisin with a rosemary extract containing 6% rosmarinic acid (6RA) and a combination of nisin with a deodorised rosemary extract containing 28% phenolic diterpenes and ⁇ 1% essential oils (28RE).
  • RA pure rosmarinic acid
  • 6RA rosemary extract containing 6% rosmarinic acid
  • 28RE deodorised rosemary extract containing 28% phenolic diterpenes and ⁇ 1% essential oils
  • Test strains Listeria monocytogenes strains 272, CRA3930 and NCTC12426
  • the chicken soup model was used as before.
  • the following samples were tested: GRE09, deodorised rosemary extracts containing 28% or 70% phenolic diterpenes (RE28 and RE70; Danisco), a water soluble rosemary extract containing 6% rosmarinic acid (6RA; Danisco) and pure rosmarinic acid (RA; Sigma). Additions to the soup were made as appropriate.
  • the soup was pasteurised (70° C./2 minutes), the pH recorded and the soup was then inoculated with a cocktail of Listeria cells prepared as described before. The tests were incubated at 20° C. and viable count enumeration performed after 0, 2, 4 and 24 h at 20 ° C. Initial Listeria levels were 1.3 ⁇ 10 5 CFU/ml.
  • the test was repeated at two nisin levels and over different time periods.
  • the pH of the soup without addition was pH 6.06-6.20.
  • Addition of rosmarinic acid at 0.1% resulted in a slight pH drop to pH 5.75.
  • Addition of 6% RA resulted in a soup pH of pH 5.75-5.78.
  • Addition of 0.5% RE28 resulted in a soup pH of pH 5.98.
  • Addition of 0.5% RE70 resulted in a soup pH of pH 6.10.
  • Addition of 0.5% GRE09 resulted in a soup pH of pH 6.02-6.09.
  • Results shown in FIGS. 4 and 5 , indicate that all the deodorised extracts tested and rosmarinic acid contributed to synergy with nisin in achieving kill of Listeria cells. This could not be attributed to the drop in pH caused by some of the additions. The additional synergy with Tween 80 was observed in GRE09. The results indicate that the antioxidant compounds carnosol and carnosic acid, present at 28 and 70% in two of the extracts tested, synergistically enhanced the cidal and growth inhibitory activity of nisin against Listeria monocytogenes. A nisin synergy with rosmarinic acid was evident but not as strong.
  • nisin as Nisaplin®, Danisco
  • Rosemary extract containing 28% phenolic diterpenes RE28
  • a blend of nisin with the Rosemary extract at levels of 50 IU/mg and 4.2% phenolic diterpenes were added to commercial chicken soup that contained no other preservatives.
  • the soup pH 5.8 was pasteurised at a core temperature of 70° C. for 2 minutes.
  • the soup was cooled to ambient temperature and either inoculated with a cocktail of stationary phase cells of Listeria monocytogenes strains or spores of Bacillus cereus.
  • the strain cocktails comprised: L.
  • the sauce was prepared from lean minced beef (50%), tomatoes and juice (48.9%), starch (0.5%), saKt (0.4%) and sucrose (0.2%).
  • the beef was fried for 5 minutes until brown, then the dry ingredients mixed in followed by the tomatoes with juice.
  • the sauce was simmered for 10 minutes and allowed to cool before blending to a smooth consistency. Final pH was 5.13. Additions were made of nisin, rosemary extract and blends.
  • the sauce was pasteurised to a core temperature of 80° C. for 2 minutes.
  • a cocktail of Listeria monocytogenes strains (as above) were inoculated after pasteurisation and the tests incubated at 8° C.
  • Results The results, shown as the time taken for bacterial numbers to reach 10 6 CFU/g, are summarised in Table 6. These show that the rosemary extract alone had no activity against Bacillus, and only slight activity against Listeria. The rosemary extract significantly enhanced the growth inhibitory activity of nisin. TABLE 6 Summary of results demonstrating nisin/phenolic diterpene synergy against Listeria in a pasteurised meat sauce at 8° C.
  • test blends contained 1) 100 IU/g nisin+30 ppm rosemary extract (i.e. 8.4 phenolic diterpenes), and 2) 150 IU/g nisin+45 ppm rosemary extract (i.e. 12.6 phenolic diterpenes).

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Agronomy & Crop Science (AREA)
  • Dentistry (AREA)
  • Environmental Sciences (AREA)
  • Pest Control & Pesticides (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nutrition Science (AREA)
  • Dispersion Chemistry (AREA)
  • Mycology (AREA)
  • Biotechnology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Toxicology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Virology (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Food Preservation Except Freezing, Refrigeration, And Drying (AREA)
  • Botany (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
  • General Preparation And Processing Of Foods (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

The present invention provides a composition comprising (a) an antimicrobial material; and (b) an extract obtained from or obtainable from a plant of the Labiatae family, wherein (a) and (b) are different; wherein the composition contains phenolic diterpenes in an amount of greater than 1.0 wt. %, based on the composition, and wherein when the antimicrobial material consists of nisin, the composition comprises carvacrol in an amount of less than 0.075 wt. % based on the composition and carvone in an amount of less than 15 wt. % based on the composition.

Description

  • The present invention relates to a composition that exhibits a microbicidal or microbiostatic action.
    • BACKGROUND
  • Bacteriocins are antimicrobial proteins or peptides that can be produced by certain bacteria, which can kill or inhibit the growth of closely related bacteria. The bacteriocins produced by lactic acid bacteria are of particular importance since they have great potential for the preservation of food and for the control of foodborne pathogens. (Wessels et al. 1998.)
  • The most well known bacteriocin is nisin, which is the only bacteriocin currently authorised as a food additive. Nisin is produced by fermentation of the dairy starter culture bacterium Lactococcus lactis subsp. lactis, and is sold as the commercial extract Nisaplin® Natural Antimicrobial (Danisco). Nisin has an unusually broad antimicrobial spectrum for a bacteriocin, being active against most Gram-positive bacteria (e.g. species of Bacillus, Clostridium, Listeria, lactic acid bacteria). It is not normally effective against Gram-negative bacteria, yeasts or moulds. Nisin is allowed as a food preservative worldwide but its levels of use and approved food applications are strictly regulated, varying from country to country.
  • Other bacteriocins have since been discovered with potential as food preservatives, e.g. pediocin, lactcin, sakacin, lactococcin, enterococin, plantaricin, leucocin. These are also active, although usually with a more narrow spectrum, against Gram-positive bacteria. Their food use is at present restricted to production of the bacteriocin in situ, i.e. by growth of the producer organism within the food.
  • Antioxidants are widely used in food products susceptible to oxidative degeneration. An antioxidant is defined by the Food and Drug Administration (21 CFR 170.3) as “a substance used to preserve food by retarding deterioration, rancidity, or discoloration due to oxidation”. Spices or plant extracts can be used in food as antioxidants and to impart flavour. One advantage of such extracts is that they are perceived as natural ingredients when compared to chemical antioxidants such as butyl hydroxyanisol (BHA) and butylated hydoxytoluene (BHT). Plants of the family Labiatae contain several well known herbs. Extracts from these plants have been shown to have antioxidant and, in some cases, antimicrobial activity (Nychas & Skandamis, 2003; Smid and Gorris, 1999; Loliger, 1989). Such extracts may be essential oils and oleoresins (extracts with essential oil content used in flavours and fragrances) or “deodorised”, extracts that have a high phenolic diterpene content and low level of flavour-inducing compounds.
  • Essential oils are extracted by simple steam distillation of the plant material. The most effective antioxidant compounds in rosemary and sage are reported to be carnosic acid, carnosol and rosmarinic acid (Cuvelier et al. 1996). Carnosic acid, a phenolic diterpene (C20H28O4), occurs naturally in leaves of plants of the Labiatae family, particularly rosemary and sage, but also thyme and marjoram. Dried leaves of rosemary or sage contain 1.5-2.5% carnosic acid and 0.3-0.4% carnosol (US6231896). Carnosol is an oxidative artefact of carnosic acid (Wenkert et al. J. Org. Chem 30:2931, 1965). The oxidation takes place in the presence of harvesting in the leaves left to dry in the air and if the leaves are subjected to extraction with solvents. Rosmanol may also be a product of the oxidation of carnosic acid.
  • The use of extracts of plant material for inhibiting the growth of micro-organisms has been taught in the art. Examples of such teachings include: WO 02/069741 teaches Labiatae herb extracts and hop extracts for extending the colour lie and inhibiting the growth of micro-organisms in fresh meat, fish and poultry. Periago et al. 2001. Food Science & Technology International. 7: 487-492 relates to the use of Carvacrol and thymol at 0.3 mmol/litre in combination with nisin. It is taught that synergy is observed. JP 2001172159 relates to cosmetics comprising a range of components including antimicrobial agent and Labiatae solvent extract. WO 98/56395 teaches a mix of tea-tree oil and thyme Essential oil. GB 2275 194 A discusses plant extract disinfectant. US 6083921 discusses a combination of plant extracts including one from Labiatae: Scutellaria, preferably root (Radix scutellariae). U.S. Pat. No. 5,472,684 teaches an oral composition for plaque and gingivitis containing thymol and eugenol
  • Food safety and prevention of food spoilage is an ever present concern worldwide, particularly with the increasing trend for convenience foods such as ready to eat meals, soups, sauces or snacks. Spoilage of food is a major economic problem for the food manufacturer. Food manufacturers need to protect the health and safety of the public by delivering products that are safe to eat. Such food must have a guaranteed shelf life, either at chilled or ambient temperature storage. Consumers prefer good tasting food of high quality—this is difficult to achieve with chemical preservatives, harsh heating regimes and other processing measures. Food safety and protection is best achieved with a multiple preservation system using a combined approach of milder processing and natural preservatives. Foodborne micro-organisms are also less able to adapt and grow in food preserved with different preservative measures.
  • There is much concern about food safety and the growth of food pathogens such as Listeria monocytogenes. This particular pathogen can grow at low temperatures, which are often used as an additional preservative measure. Foodborne pathogens can sometimes adapt to different preservatives and storage conditions, thus a combination of preservative measures can be more successful than individual measures.
  • There is an increasing need to develop economical, natural and effective food preservative systems to meet the public demand for convenient, natural, safe, healthy, good quality food products with guaranteed shelf life. Bacteriocins such as nisin can be used as preservatives in food to help meet this need. Nisin is a proven safe, natural preservative with GRAS status. Other bacteriocins can be used for preservation if produced in situ, by growth of the bacteriocin producer organism in the food.
  • In some cases the bacteriocin levels required to ensure preservation or food safety may prove uneconomical, or are below effective levels due to regulatory and legislation constraints. When bacteriocins are produced in situ, the resulting bacteriocin levels may not be high enough to achieve the required preservative effect.
  • The present invention alleviates the problems of the prior art.
  • In one aspect the present invention provides a composition comprising (a) an antimicrobial material; and (b) an extract obtained from or obtainable from a plant of the Labiatae family, wherein (a) and (b) are different; wherein the composition contains phenolic diterpenes in an amount of greater than 1.0 wt. %, based on the composition, and wherein when the antimicrobial material consists of nisin, the composition comprises carvacrol in an amount of less than 0.075 wt. % based on the composition and carvone in an amount of less than 15 wt. % based on the composition.
  • In one aspect the present invention provides a process for preventing and/or inhibiting the growth of, and/or killing a microorganism in a material, the process comprising the step of contacting the material with (a) an antimicrobial material; and (b) an extract obtained from or obtainable from a plant of the Labiatae family, wherein (a) and (b) are different; wherein the composition contains phenolic diterpenes in an amount of greater than 1.0 wt. %, based on the composition, and wherein when the antimicrobial material consists of nisin, the composition comprises carvacrol in an amount of less than 0.075 wt. % based on the composition and carvone in an amount of less than 15 wt. % based on the composition.
  • In one aspect the present invention provides use of (a) an antimicrobial material; and b) an extract obtained from or obtainable from a plant of the Labiatae family, for preventing and/or inhibiting the growth of, and/or killing a micro-organism in a material; wherein (a) and (b) are different; wherein the composition contains phenolic diterpenes in an amount of greater than 1.0 wt. %, based on the composition, and wherein when the antimicrobial material consists of nisin, the composition comprises carvacrol in an amount of less than 0.075 wt. % based on the composition and carvone in an amount of less than 15 wt. % based on the composition.
  • In one aspect the present invention provides kit for preparing a composition as defined herein, the kit comprising (a) an antimicrobial material; and (b) an extract obtained from or obtainable from a plant of the Labiatae family, wherein (a) and (b) are different; wherein the composition contains phenolic diterpenes in an amount of greater than 1.0 wt. %, based on the composition, and wherein when the antimicrobial material consists of nisin, the composition comprises carvacrol in an amount of less than 0.075 wt. % based on the composition and carvone in an amount of less than 15 wt. % based on the composition, in separate packages or containers; optionally with instructions for admixture and/or contacting and/or use.
  • Aspects of the invention are defined in the appended claims.
  • Of the Labiatae plant family, rosemary and sage have antioxidant activity in foods that is mainly related to phenolic diterpenes such as carnosic acid and carnosol, as well as other phenolic compounds, including phenolic triterpenes such as betulinic acid, oleanolic add and ursolic acid; and rosmarinic acid. Antimicrobial activity has been attributed to some of these compounds, all of which can be obtained by selective extraction from the plants. The phenolic diterpenes, phenolic triterpenes and rosmarinic acid are distinct from the essential oils and oleoresins that are often used in flavours and fragrances. The high flavour and odour levels of essential oils is not conducive to their use in food. One skilled in the art would expect a combination of an antimicrobial material and an extract from the Labiatae plant family to provide a simple additive bactericidal or bacteriostatic effect. However, in vitro studies described herein have demonstrated synergistic enhancement of bacteriocin activity by a deodorised extract of Rosmarinus officinalis. This enhanced activity was also observed in a food model, increasing bacteriocin (for example nisin) kill and growth control of Gram-positive bacteria. Enhanced bacteriocin activity was also observed with rosemary extracts specifically prepared to contain high levels of the phenolic diterpenes carnosol and carnosic acid, indicating these compounds play an important role in the synergy. Enhanced bacteriocin activity was also observed with rosmarinic acid.
  • The present invention provides a synergistic combination of components for preventing and/or inhibiting the growth of, and/or killing a micro-organism in a material, such as foodstuff. This combination of components allows lower levels of the antimicrobial material to be used to provide effective action and prevent the development of tolerance to the antimicrobial material. This is particularly important in food applications where reduction of dosage and/or avoidance of development of tolerance is desired for commercial and regulatory reasons.
  • For ease of reference, these and further aspects of the present invention are now discussed under appropriate section headings. However, the teachings under each section are not necessarily limited to each particular section.
  • Preferred Aspects
  • Antimicrobial Material
  • In one preferred aspect the antimicrobial material is a bacteriocin.
  • The antimicrobial material, such as a bacteriocin, may typically be selected from materials (bacteriocins) that can be used as preservatives in food
  • Preferably the antimicrobial material is selected from lanthionine containing bacteriocins, Lactococcus-derived bacteriocins, Streptococcus-derived bacteriocins, Pediococcus-derived bacteriocins, Lactobacillus-derived bacteriocins, Carnobacterium-derived bacteriocins, Leuconostoc-derived bacteriocins, Enterococcus-derived bacteriocins and mixtures thereof
  • Preferably the antimicrobial material is at least nisin.
  • Preferably the antimicrobial material consists of nisin.
  • Nisin is a lanthionine-containing bacteriocin (U.S. Pat. No. 5,691,301) derived from Lactococcus lactis subsp. lactis (formerly known as Streptococcus-lactis) (U.S. Pat. No. 5,573,801). In a preferred aspect of the present invention the bacteriocin used in the present invention is at least nisin.
  • As discussed in U.S. Pat. No. 5,573,801 nisin is a polypeptide bacteriocin produced by the lactic acid bacteria, Lactococcus lactis subsp. lactis (formerly known as Streptococcus lactis Group N).
  • Nisin is reportedly a collective name representing several closely related substances which have been designated nisin compounds A, B, C, D and E (De Vuyst, L. and Vandamme, E. J. 1994. Nisin, a lantibiotic produced by Lactococcus lactis subsp. lactis: properties, biosynthesis, fermentation and applications. In: Bacteriocins of lactic acid bacteria. Microbiology, Genetics and Applications. Eds.: De Vuyst and Vandamme. Blackie Academic and Professional, London). The structure and properties of nisin are also discussed in the article by E. Lipinska, entitled “Nisin and Its Applications”, The 25th Proceedings of the Easter School in Agriculture Science at the University of Nottingham, 1976, pp. 103-130 (1977), which article is hereby incorporated by reference. In 1969 the FAO/WHO Joint Expert Committee on Food Additives set specifications for the purity and identity of nisin (FAO/WHO Joint Expert Committee on Food Additives. 1969. Specifications for identity and purity of some antibiotics. 12th Report. WHO Technical Report Series No. 430). This committee recognised nisin as a safe and legal preservative based on extensive toxicological testing. Nisin has the food additive number E234 and is classed as GRAS (Generally Recognised As Safe) (Food and Drug Administration. 1988. Nisin preparation: Affirmation of GRAS status as a direct human ingredient. Federal Regulations 53: 11247). The international activity unit (IU hereinafter) was defined as 0.001 mg of an international nisin reference preparation. Nisaplin® Natural Antimicrobial is the brand name for a nisin concentrate containing 1 million IU per g, which is commercially available from Danisco.
  • Nisin is an acknowledged and accepted food preservative with a long history of safe, effective food use. There have been several reviews of nisin, e.g. Hurst 1981; 1983; Delves-Broughton, 1990; De Vuyst and Vandamme, 1994; Thomas et al. 2000; Thomas & Delves-Broughton, 2001). Nisin was discovered over 50 years ago and the first commercial preparation, made in 1953, was Nisaplin®. Nisin has several characteristics that make it particularly suitable as a food preservative. It has undergone extensive toxicological testing to demonstrate its safety. It is heat-stable, acid-stable and effective against a broad spectrum of Gram-positive bacteria. It is not normally effective against Gram-negative bacteria, yeasts or moulds but activity against Gram-negative bacteria and yeasts has been reported in the presence of chelating agents (PCT/US 8902625. WO 89/12399). Nisin is an effective preservative in pasteurised and heat-treated foods (e.g. processed cheese, cheese, pasteurised milks, dairy desserts, cream, mascarpone and other dairy products, puddings such as semolina, tapioca etc., pasteurised liquid egg, pasteurised potato products, soy products, crumpets, pikelets, flapjacks, processed meat products, beverages, soups, sauces, ready to eat meals, canned foods, vegetable drinks) and low acid foods such as salad dressings, sauces, mayonnaise, beer, wine and other beverages.
  • Although some loss of activity may be expected when used with processed foods, this may be ameliorated e.g. by increasing the amount of nisin applied. Effective levels of nisin to preserve foodstuffs reportedly range from 25-500 IU/g or more. Other effective levels would be appreciated by one skilled in the art. For example levels of 50-400 IU/g may be utilised.
  • Since the discovery of the first bacteriocin, nisin, many other bacteriocins have now been found (Hoover, 1993; Ray & Daeschel, 1994; Axelsen, 1998; Naidu, 2000; Ray et al. 2001; Ray & Miller, 2003). The bacteriocin pediocin, produced by Pediococcus pentosaceus, P. acidilactici, or Lactobacillus plantarum, may be used in the present invention. Like nisin, different structures of pediocin have been described. At present pediocin and other bacteriocins are not allowed as food additives but their antibacterial activity can be achieved by production of the bacteriocin in situ, as a consequence of the growth of the producer organism in the food. This is the purpose of commercial s protective cultures such as HOLDBAC™ Listeria (Danisco). Pediocin has a more narrow antimicrobial spectrum compared to nisin, but there is much interest in its food safety ability to kill, prevent or control the growth of the food pathogen Listeria monocytogenes (Ray & Miller, 2000). Other bacteriocins may be used in the present invention, including those named generally as divercin, leucocin, mesentericin, sakacin, curvacin, bavaricin, acidocin, bifidocin, carnobacteriocin, pisicocin, piscicolin, mundticin, enterocin, thermophilin, lacticin, plantaricin, lactococcin, divercin, diplococcin, mesenterocin, leuconosin, camosin, acidophilin, lactacin, brevicin, lactocin, helevticin, reutericin, propionicin.
  • Extract
  • As discussed herein when the antimicrobial material consists of nisin, the composition comprises carvacrol in an amount of less than 0.075 wt. % based on the composition and carvone in an amount of less than 15 wt. % based on the composition.
  • In one preferred aspect when the antimicrobial material consists of nisin, the composition comprises carvacrol in an amount of less than 0.05 wt. % based on the composition, preferably less than 0.04 wt. %, preferably less than 0.02 wt. %, preferably less than 0.01 wt. %, preferably less than 0.004 wt. %, based on the composition.
  • In one preferred aspect, the composition comprises carvacrol in an amount of less than 0.05 wt. % based on the composition, preferably less than 0.04 wt. %, preferably less than 0.02 wt. %, preferably less than 0.01 wt. %, preferably less than 0.004 wt. %, based on the composition.
  • In one preferred aspect when the antimicrobial material consists of nisin, the composition comprises carvone in an amount of less than 10 wt. % based on the composition, preferably less than 7 wt. %, preferably less than 5 wt. %, preferably less than 2 wt. %, preferably less than 1 wt. %, preferably less than 0.75 wt. %, preferably less than 0.5 wt. %, preferably less than 0.2 wt. %, preferably less than 0.1 wt. %, preferably less than 0.075 wt. %, preferably less than 0.05 wt. %, preferably less than 0.04 wt. %, preferably less than 0.02 wt. %, preferably less than 0.01 wt. %, preferably less than 0.004 wt. %, based on the composition.
  • In one preferred aspect the composition comprises carvone in an amount of less than 10 wt. % based on the composition, preferably less than 7 wt. %, preferably less than 5 wt. %, preferably less than 2 wt. %, preferably less than 1 wt. %, preferably less than 0.75 wt. %, preferably less than 0.5 wt. %, preferably less than 0.2 wt. %, preferably less than 0.1 wt. %, preferably less than 0.75 wt. %, preferably less than 0.05 wt. %, preferably less than 0.04 wt. %, preferably less than 0.02 wt. %, preferably less than 0.01 wt. %, preferably less than 0.004 wt. %, based on the composition.
  • In one preferred aspect when the antimicrobial material consists of nisin, the composition comprises thymol in an amount of less than 1 5 wt. % based on the composition, preferably less than 10 wt. %, preferably less than 7 wt. %, preferably less than 5 wt. %, preferably less than 2 wt. %, preferably less than 1 wt. %, preferably less than 0.75 wt. %, preferably less than 0.5 wt. %, preferably less than 0.2 wt. %, preferably less than 0.1 wt. %, preferably less than 0.075 wt. %, preferably less than 0.05 wt. %, preferably less than 0.04 wt. %, preferably less than 0.02 wt. %, preferably less than 0.01 wt. %, preferably less than 0.004 wt. %, based on the composition.
  • In one preferred aspect the composition comprises thymol in an amount of less than 15 wt. % based on the composition preferably less than 10 wt. %, preferably less than 7 wt. %, preferably less than 5 wt. %, preferably less than 2 wt. %, preferably less than 1 wt. %, preferably less than 0.75 wt. %, preferably less than 0.5 wt. %, preferably less than 0.2 wt. %, preferably less than 0.1 wt. %, preferably less than 0.075 wt. %, preferably less than 0.05 wt. %, preferably less than 0.04 wt. %, preferably less than 0.02 wt. %, preferably less than 0.01 wt. %, preferably less than 0.004 wt. %, preferably less than 0.004 wt. %, based on the composition.
  • In one preferred aspect when the antimicrobial material consists of nisin, the composition comprises eugenol in an amount of less than 15 wt. % based on the composition, preferably less than 10 wt. %, preferably less than 7 wt. %, preferably less than 5 wt. %, preferably less than 2 wt. %, preferably less than 1 wt. %, preferably less than 0.75 wt. %, preferably less than 0.5 wt. %, preferably less than 0.2 wt. %, preferably less than 0.1 wt. %, preferably less than 0.075 wt. %, preferably less than 0.05 wt. %, preferably less than 0.04 wt. %, preferably less than 0.02 wt. %, preferably less than 0.01 wt. %, preferably less than 0.004 wt. %, based on the composition.
  • In one preferred aspect the composition comprises eugenol in an amount of less than 15 wt. % based on the composition preferably less than 10 wt. %, preferably less than 7 wt. %, preferably less than 5 wt. %, preferably less than 2 wt. %, preferably less than 1 wt. %, preferably less than 0.75 wt. %, preferably less than 0.5 wt. %, preferably less than 0.2 wt. %, preferably less than 0.1 wt. %, preferably less than 0.075 wt. %, preferably less than 0.05 wt. %, preferably less than 0.04 wt. %, preferably less than 0.02 wt. %, preferably less than 0.01 wt. %, preferably less than 0.004 wt. %, based on the composition.
  • In one preferred aspect when the antimicrobial material consists of nisin, the composition comprises carvacrol in an amount of less than 0.075 wt. % based on the composition and each of carvone and thymol in amounts of less than 15 wt. % based on the composition (preferably less than 10 wt. % based on the composition, preferably less than 7 wt. %, preferably less than 5 wt. %, preferably less than 2 wt. %, preferably less than 1 wt. %, preferably less than 0.75 wt. %, preferably less than 0.5 wt. %, preferably less than 0.2 wt. %, preferably less than 0.1 wt. %, preferably less than 0.075 wt. %, preferably less than 0.05 wt. %, preferably less than 0.04 wt. %, preferably less than 0.02 wt. %, preferably less than 0.01 wt. %, preferably less than 0.004 wt. %, based on the composition).
  • In one preferred aspect, the composition comprises carvacrol in an amount of less than 0.075 wt. % based on the composition and each of carvone and thymol in amounts of less than 15 wt. % based on the composition (preferably less than 10 wt. % based on the composition, preferably less than 7 wt. %, preferably less than 5 wt. %, preferably less than 2 wt. %, preferably less than 1 wt. %, preferably less than 0.75 wt. %, preferably less than 0.5 wt. %, preferably less than 0.2 wt. %, preferably less than O.1 wt. %, preferably less than 0.075 wt. %, preferably less than 0.05 wt. %, preferably less than 0.04 wt. %, preferably less than 0.02 wt. %, preferably less than 0.01 wt. %, preferably less than 0.004 wt. %, based on the composition).
  • In one preferred aspect when the antimicrobial material consists of nisin, the composition comprises carvacrol in an amount of less than 0.075 wt. % based on the composition and each of carvone, thymol and eugenol in amounts of less than 15 wt. % based on the composition (preferably less than 10 wt. % based on the composition, preferably less than 7 wt. %, preferably less than 5 wt. %, preferably less than 2 wt. %, preferably less than 1 wt. %, preferably less than 0.75 wt. %, preferably less than 0.5 wt. %, preferably less than 0.2 wt. %, preferably less than 0.1 wt. %, preferably less than 0.075 wt. %, preferably less than 0.05 wt. %, preferably less than 0.04 wt. %, preferably less than 0.02 wt. %, preferably less than 0.01 wt. %, preferably less than 0.004 wt. %, based on the composition).
  • In one preferred aspect, the composition comprises carvacrol in an amount of less than 0.075 wt. % based on the composition and each of carvone, thymol and eugenol in amounts of less than 15 wt. % based on the composition (preferably less than 10 wt. % based on the composition, preferably less than 7 wt. %, preferably less than 5 wt. %, preferably less than 2 wt. %, preferably less than 1 wt. %, preferably less than 0.75 wt. %, preferably less than 0.5 wt. %, preferably less than 0.2 wt. %, preferably less than 0.1 wt. %, preferably less than 0.075 wt. %, preferably less than 0.05 wt. %, preferably less than 0.04 wt. %, preferably less than 0.02 wt. %, preferably less than 0.01 wt. %, preferably less than 0.004 wt. %, based on the composition).
  • In one preferred aspect when the antimicrobial material consists of nisin, the composition comprises each of carvacrol and carvone in an amount of less than 1 wt. % based on the extract. Preferably when the antimicrobial material consists of nisin the composition comprises each of carvacrol and carvone in an amount of less than 0.075 wt. %, preferably less than 0.05 wt. %, preferably less than 0.04 wt. %, preferably less than 0.02 wt. %, preferably less than 0.01 wt. %, preferably less than 0.004 wt. %, based on the extract.
  • In one preferred aspect when the antimicrobial material consists of nisin, the composition comprises each of carvacrol, carvone and thymol in amounts of less than 1 wt. % based on the extract. Preferably when the antimicrobial material consists of nisin the composition comprises each of carvacrol, carvone and thymol in an amount of less than 0.075 wt. %, preferably less than 0.05 wt. %, preferably less than 0.04 wt. %, preferably less than 0.02 wt. %, preferably less than 0.01 wt. %, preferably less than 0.004 wt. %, based on the extract.
  • In one preferred aspect when the antimicrobial material consists of nisin, the composition comprises each of carvacrol, carvone, thymol and eugenol in amounts of less than 1 wt. % based on the extract. Preferably when the antimicrobial material consists of nisin the composition comprises each of carvacrol, carvone, thymol and eugenol in an amount of less than 0.075 wt. %, preferably less than 0.05 wt. %, preferably less than 0.04 wt. %, preferably less than 0.02 wt. %, preferably less than 0.01 wt. %, preferably less than 0.004 wt. %, based on the extract.
  • In one preferred aspect the composition comprises each of carvacrol and carvone in an amount of less than 1 wt. % based on the extract. Preferably the composition comprises each of carvacrol and carvone in an amount of less than 0.075 wt. %, preferably less than 0.05 wt. %, preferably less than 0.04 wt. %, preferably less than 0.02 wt. %, preferably less than 0.01 wt. %, preferably less than 0.004 wt. %, based on the extract.
  • In one preferred aspect the composition comprises each of carvacrol, carvone and thymol in amounts of less than 1 wt. % based on the extract. Preferably the composition comprises each of carvacrol, carvone and thymol in an amount of less than 0.075 wt. %, preferably less than 0.05 wt. %, preferably less than 0.04 wt. %, preferably less than 0.02 wt. %, preferably less than 0.01 wt. %, preferably less than 0.004 wt. %, based on the extract.
  • In one preferred aspect the composition comprises each of carvacrol, carvone, thymol and eugenol in amounts of less than 1 wt. % based on the extract. Preferably the composition comprises each of carvacrol, carvone, thymol and eugenol in an amount of less than 0.075 wt. %, preferably less than 0.05 wt. %, preferably less than 0.04 wt. %, preferably less than 0.02 wt. %, preferably less than 0.01 wt. %, preferably less than 0.004 wt. %, based on the extract.
  • The extract used in the present invention is obtained from or is obtainable from a plant of the Labiatae family.
  • In one aspect the extract used in the present invention is obtained from a plant of the Labiatae family.
  • It will be appreciated by one skilled in the art that by the term “extract” or “extracts” it is meant any constituent of the plant which may be isolated from the whole plant.
  • In one aspect the extract used in the present invention is obtainable from a plant of the Labiatae family. It will be appreciated by one skilled in the art that an extract obtainable from a plant may be obtained from a plant or may be isolated from the plant, identified and then obtained from an alternative source, for example by chemical synthesis or enzymatic production. For example the extract may be produced by a eukaryotic or prokaryotic fermentation, by a process of genetic manipulation. The present applicant have recognised that products present in a plant of the Labiatae family may synergistically increase the activity of a an antimicrobial material, preferably a bacteriocin. These products may be obtained from any source and will fall within the scope of the present invention.
  • The invention comprises use of a combination of a bacteriocin such as nisin and a of the Labiatae plant family, such as rosemary (Rosmarinus officinalls) or sage (Salvia officinalis) that together give enhanced control of Gram-positive bacteria in a food system. The extracts responsible for synergy in the present invention preferably refer to extracts of the plant family Labiatae that have been selectively extracted (“deodorised extracts”) to increase their phenolic diterpene content (such as carnosol and carnosic acid), phenolic tripterpene content (such as ursolic acid, betulinic acid and oleanolic acid) or rosmarinic acid content. These deodorised extracts can be distinguished by their high phenolic diterpene content (for example greater than 3.5 wt. %) and their low level (less than 1 wt. %) of flavour-inducing compounds from plant essential oils and oleoresins that are used as flavours or fragrances. Essential oils are typically extracted by simple steam distillation of the plant material.
  • Essential oils comprise the various essential oils in plants having the odour or the flavour of the plant from which they were extracted. The essential oils are typically terpenoids often comprising monoterpenes. For example an antioxidant type of rosemary extract, which could be described as selectively extracted or deodorised, contains >3.5% phenolic diterpenes but less than 1 wt. % essential oils. A non-selective, flavouring extract contains 10-30 wt. % essential oils and a phenolic diterpene content of 2->3.5 wt. %.
  • An essential oil is commonly described as the volatile ethereal fraction obtained from a plant or plant part by a physical separation process such as distillation or chromatographic separation. Essential oils have also been described as a “group of odorous principles, soluble in alcohol and to a limited extent in water, consisting of a mixtures of esters, aldehydes, ketones and terpenes. Essential oils are typically obtained by distilling plants with water; the oil that separates from distillate usually has highly characteristic odors identified with the plant origin. The resulting mixture of organic compounds was thought, in the days of alchemists, to be the essence of the plant, hence the term “essential oil”.
  • In one preferred aspect the extract is a deodorised extract. Preferably the (deodorised) extract contains from 1.0 to 70 wt. % phenolic diterpenes, preferably 3.5 to 70 wt. % phenolic diterpenes and less than 1 wt. % essential oil.
  • In one preferred aspect the extract is selected from phenolic diterpenes, phenolic triterpenes and rosmarinic acid.
  • In one preferred aspect the extract is or comprises a phenolic diterpene. Preferably the phenolic diterpene is selected from carnosic acid, carnosol and methylcarnosic acid. Preferably the phenolic diterpene is selected from carnosic acid and carnosol.
  • In one preferred aspect the combined amount of phenolic diterpenes, and phenolic triterpenes and rosmarinic acid, based on the extract, is greater than 1.0 wt. %. In one preferred aspect the combined amount of phenolic diterpenes, and phenolic triterpenes and rosmarinic acid, based on the composition, is greater than 1.0 wt. %.
  • In one preferred aspect the combined amount of phenolic diterpenes, and phenolic triterpenes and rosmarinic acid, based on the extract, is greater than 3.5 wt. %. In one preferred aspect the combined amount of phenolic diterpenes, and phenolic triterpenes and rosmarinic acid, based on the composition, is greater than 3.5 wt. %.
  • In one preferred aspect the amount of phenolic diterpenes, based on the extract, is greater than 1.0 wt. %, for example greater than 5.0 wt. %, greater than 10.0 wt. %, greater than 20.0 wt. %, or greater than 25.0 wt. %. In one preferred aspect the amount of phenolic diterpenes, based on the composition, is greater than 1.0 wt. %.
  • In one preferred aspect the amount of phenolic diterpenes, based on the extract, is greater than 3.5 wt. %. In one preferred aspect the amount of phenolic diterpenes, based on the composition, is greater than 3.5 wt. %.
  • In one preferred aspect the amount of phenolic diterpenes, based on the composition, is greater than 1.0 wt. %, preferably greater than 2.0 wt. %, preferably greater than 3.0 wt. %, preferably greater than 3.5 wt. %, preferably greater than 5.0 wt. %, preferably greater than 10.0 wt. %, preferably greater than 20.0 wt. %, preferably greater than 40.0 wt. %, preferably greater than 50.0 wt. %.
  • In one preferred aspect the amount of phenolic diterpenes, based on the composition, is from 2.0 to 2.5 wt. %, such as 2.3 wt. %.
  • In one preferred aspect the amount of phenolic diterpenes, based on the composition, is from 4.0 to 4.5 wt. %, such as 4.2 wt. %.
  • In one preferred aspect the amount of phenolic diterpenes, based on the extract, is greater than 1.0 wt. %, preferably greater than 2.0 wt. %, preferably greater than 3.0 wt. %, preferably greater than 3.5 wt. %, preferably greater than 5.0 wt. %, preferably greater than 10.0 wt. %, preferably greater than 20.0 wt. %, preferably greater than 40.0 wt. %, preferably greater than 50.0 wt. %.
  • In one highly preferred aspect the extract contains one or more phenolic triterpenes. Preferably the phenolic triterpenes are selected from betulinic acid, oleanolic acid, and ursolic acid.
  • In one preferred aspect is or comprises a phenolic triterpene. Preferably the phenolic triterpene is selected from betulinic acid, oleanolic acid, and ursolic acid.
  • In one highly preferred aspect the amount of phenolic triterpenes, based on the extract, is greater than 3.5 wt. %. In one highly preferred aspect the amount of phenolic triterpenes, based on the composition, is greater than 3.5 wt. %.
  • In one preferred aspect the extract is or comprises rosmarinic acid.
  • In one preferred aspect the amount of rosmarinic acid, based on the extract, is greater than 3.5 wt. %. In one preferred aspect the amount of rosmarinic acid, based on the composition, is greater than 3.5 wt. %.
  • In one preferred aspect the extract contains flavour-inducing compounds and/or essential oils in an amount of less than 1 wt. % based on the extract. In one preferred aspect the extract contains flavour-inducing compounds and/or essential oils in an amount of less than 1 wt. % based on the composition.
  • Typically flavour-inducing compounds and/or essential oils are camphor, verbenone, borneol and alfa-terpineol.
  • In one preferred aspect the combined amount of camphor present in the extract is less than 1 wt. % (preferably less than 0.2 wt. %, more preferably less than 0.15 wt. %, more preferably less than 0.1 wt. %) based on the extract.
  • In one preferred aspect the combined amount of verbenone present in the extract is less than 1 wt. % (preferably less than 0.2 wt. %, more preferably less than 0.15 wt. %, more preferably less than 0.1 wt. %) based on the extract.
  • In one preferred aspect the combined amount of borneol present in the extract is less than 1 wt. % (preferably less than 0.2 wt. %, more preferably less than 0.15 wt. %, more preferably less than 0.1 wt. %) based on the extract.
  • In one preferred aspect the combined amount of alfa-terpineol present in the extract is less than 1 wt. % (preferably less than 0.2 wt. %, more preferably less than 0.15 wt. %, more preferably less than 0.1 wt. %) based on the extract.
  • In one preferred aspect the combined amount of camphor, verbenone, borneol and alfa-terpineol present in the extract is less than 1 wt. % (preferably less than 0.2 wt. %, more preferably less than 0.15 wt. %, more preferably less than 0.1 wt. %) based on the extract.
  • In one preferred aspect the extract contain less than 1 wt. % of plant essential oils and/or oleoresins based on the extract. In one preferred aspect the extract contain less than 1 wt. % of plant essential oils and/or oleoresins based on the composition.
  • In one preferred aspect the extract contains essential oils in an amount of less than 1 wt. % based on the extract. In one preferred aspect the extract contains essential oils in an amount of less than 1 wt. % based on the composition.
  • In one preferred aspect the plant of the Labiatae family is selected from rosemary, sage, oregano, marjoram, mint, balm, savoury and thyme. In one preferred aspect the plant of the Labiatae family is selected from rosemary, sage, oregano, marjoram, mint, balm, and savoury. It will be understood that these name cover all species and varieties of plants known by these names.
  • In one preferred aspect the plant of the Labiatae family is selected from rosemary (Rosmarinus officinalis L.), sage (Salvia officinalis L.) oregano (Origanum vulgare L.), marjoram (Origanum marjorana L.), mint (Mentha spp.), balm (Melissa officinalis L.), savoury (Satureia hortensis), thyme (Thymus vulgaris L.).
  • In one preferred aspect the plant of the Labiatae family is selected from rosemary (Rosmarinus officinalis L.), sage (Salvia officinalis L.), oregano (Origanum vulgare L.), marjoram (Origanum mailorana L.), mint (Mentha spp.), balm (Melissa officinalis L.), and savoury (Satureia hortensis).
  • In one preferred aspect the plant of the Labiatae family is selected from rosemary (Rosmarinus officinalis L.), sage (Salvia officinalis L.), marjoram (Origanum marjorana L.), mint (Mentha spp.), balm (Melissa officinalis L.), and savoury (Satureia hortensis).
  • In one preferred aspect the plant of the Labiatae family is rosemary.
  • In a further preferred aspect the phenolic diterpenes, phenolic triterpenes and rosmarinic acid are obtained by chemical synthesis.
  • Thus in highly preferred aspects the present invention provides
      • a composition comprising (a) an antimicrobial material and (b) a compound selected from carnosic acid, carnosol, methylcarnosic acid, betulinic acid, oleanolic acid, ursolic acid and rosmarinic acid (preferably carnosic acid and carnosol).
      • a process for preventing and/or inhibiting the growth of, and/or killing a microorganism in a material, the process comprising the step of contacting the material with (a) a bacteriocin; and (b) a compound selected from carnosic acid, carnosol, methylcarnosic acid, betulinic acid, oleanolic acid, ursolic acid and rosmarinic acid (preferably carnosic acid and carnosol).
      • use of (a) an antimicrobial material and (b) a compound selected from carnosic acid, carnosol, methylcarnosic acid, betulinic acid, oleanolic acid, ursolic acid and rosmarinic acid (preferably carnosic acid and carnosol), for preventing and/or inhibiting the growth of, and/or killing a micro-organism in a material.
        Microorganism
  • As discussed herein the present invention may prevent and/or inhibit the growth of, and/or kill a micro-organism in a material. This may be slowing or arresting a micro-organism, such a bacteria, or by killing the micro-organism present on contact with the present composition.
  • In one aspect the antimicrobial material and/or the extract are present in an amount to provide a microbicidal or microbiostatic effect.
  • In one aspect the bacteriocin and the extract are present in an amount to provide a microbicidal or microbiostatic effect.
  • In one aspect the bacteriocin and the extract are present in an amount to provide a microbicidal or microbiostatic synergistic effect.
  • In one aspect the bacteriocin and the extract are present in an amount to provide a microbicidal synergistic effect.
  • In a highly preferred aspect the microbicidal or microbiostatic effect is a bactericidal or bacteriostatic effect.
  • It is advantageous for the bactericidal or bacteriostatic effect to be in respect of Gram-positive bacteria and Gram-negative bacteria. Preferably the bactericidal or bacteriostatic effect is in respect of Gram-positive bacteria.
  • In a preferred aspect the bactericidal or bacteriostatic effect is in respect of an organism selected from Gram-positive bacteria associated with food spoilage or foodborne disease including Bacillus species, Bacillus subtilis, Bacillus cereus, Listeria species, Listeria monocytogenes, lactic acid bacteria, lactic acid spoilage bacteria, Lactobacillus species, Staphylococcus aureus, Clostridium species, C. sporogenes, C. tyrobutyricum.
  • In a preferred aspect the bactericidal or bacteriostatic effect of the invention in combination with a chelating agent is in respect of an organism selected from other micro-organisms associated with food spoilage or foodborne disease, including yeasts, moulds and Gram-negative bacteria including Escherichia coli, Salmonella species, and Pseudomonas species.
  • In a preferred aspect the bactericidal or bacteriostatic effect is in respect of an organism selected from Bacillus cereus 204, B. cereus Campden, B. cereus NCTC2599, B. subtilis Campden, Clostridium sporogenes strain Campden, Clostridium sporogenes strain 1.221, Clostridium sporogenes NCIMB1793, Listeria monocytogenes 272, L. monocytogenes NCTC12426, L. monocytogenes S23, Lactobacillus sake 272, Escherichia coil S15, E. coli CRA109, Salmonella Typhimurium S29, Pseudomonas fluorescens 3756,
  • In a preferred aspect the bactericidal or bacteriostatic effect is in respect of Listeria monocytogenes.
  • Foodstuff
  • The composition, process and use of the present invention may prevent and/or inhibit the growth of, and/or kill a micro-organism in any material. However, in view of the problems associated with spoilage and contamination of foodstuffs and in view of the particular effectiveness of the present invention in foodstuffs, preferably the composition is a foodstuff or may be added to a foodstuff. It will be appreciated by one skilled in the art that when the present composition is a foodstuff the essential components of (a) an antimicrobial material and (b) a extract obtained from or obtainable from a plant of the Labiatae family are already present in the foodstuff. They may have been provided by one or more means. For example they may have been added in the form of a composition containing the bacteriocin and the extract. The two components (the bacteriocin and the afore mentioned extract) may have been added to the foodstuff sequentially. In one further aspect one or more of the components may have be formed in situ in the foodstuff. For example the bacteriocin may be formed in situ in the foodstuff by fermentation of the dairy starter culture bacterium Lactococcus lactis subsp. lactis.
  • In one aspect the composition of the present invention is a protectant composition suitable for addition to a foodstuff.
  • Many foodstuffs may be protected by the present invention. Typical foodstuffs are raw meat, cooked meat, raw poultry products, cooked poultry products, raw seafood products, cooked seafood products, ready to eat meals, pasta sauces, pasteurised soups, mayonnaise, salad dressings, oil-in-water emulsions, margarines, low fat spreads, water-in-oil emulsions, dairy products, cheese spreads, processed cheese, dairy desserts, flavoured milks, cream, fermented milk products, cheese, butter, condensed milk products, ice cream mixes, soya products, pasteurised liquid egg, bakery products, confectionery products, fruit products, and foods with fat-based or water-containing fillings.
  • Additional Components
  • The compositon of the present invention or the composition for use in the present invention may contain one or more additional components. However, in some aspects the protectant composition of the present invention (suitable for addition to a foodstuff) contains no additional components or contains no additional components that materially affect the properties of the composition. In these aspects the present invention provides
      • a composition consisting essentially of (a) a bacteriocin and (b) an extract obtained from or obtainable from a plant of the Labiatae family, wherein (a) and (b) are different
      • a composition consisting of (a) a bacteriocin and (b) an extract obtained from or obtainable from a plant of the Labiatae family, wherein (a) and (b) are different
      • a composition consisting essentially of (a) a bacteriocin and (b) an extract obtained from or obtainable from a plant of the Labiatae family, wherein (a) and (b) are different, wherein when the antimicrobial material consists of nisin, the composition comprises carvacrol in an amount of less than 0.075 wt. % based on the composition and carvone in an amount of less than 15 wt. % based on the composition.
      • a composition consisting of (a) a bacteriocin and (b) an extract obtained from or obtainable from a plant of the Labiatae family, wherein (a) and (b) are different, wherein when the antimicrobial material consists of nisin, the composition comprises carvacrol in an amount of less than 0.075 wt. % based on the composition and carvone in an amount of less than 15 wt. % based on the composition.
  • In one preferred aspect the composition further comprises an emulsifier. Preferably the emulsifier is selected from polyoxy-ethylene sorbitan esters (E432-E436) otherwise known as polysorbates (e.g. Tween 80, Tween 20), monoglycerides, diglycerides, acetic acid esters of mono-diglycerides, tartaric acid esters of mono-diglycerides and citric acid esters of mono-diglycerides.
  • In one preferred aspect the composition further comprises a chelator. Preferably the chelator is selected from EDTA, citric acid, monophosphates, diphosphates, triphosphates and polyphosphates.
  • Further suitable chelator are taught in U.S. Pat. No. 5,573,801 and include carboxylic acids, polycarboxylic acids, amino acids and phosphates. In particular, the following compounds and their salts may be useful:
  • Acetic acid, Adenine, Adipic acid, ADP, Alanine, B-Alanine, Albumin, Arginine, Ascorbic acid, Asparagine, Aspartic acid, ATP, Benzoic acid, n-Butyric acid, Casein, Citraconic acid, Citric acid, Cysteine, Dehydracetic acid, Desferri-ferrichrysin, Desferri-ferrichrome, Desferri-ferrioxamin E, 3,4-Dihydroxybenzoic acid, Diethylenetriaminepentaacetic acid (DTPA), Dimethylglyoxime, O,O-Dimethylpurpurogallin, EDTA, Formic acid, Fumaric acid, Globulin, Gluconic acid, Glutamic acid, Glutaric acid, Glycine, Glycolic acid, Glycylglycine, Glycylsarcosine, Guanosine, Histamine, Histidine, 3-Hydroxyflavone, Inosine, Inosine triphosphate, Iron-free ferrichrome, Isovaleric acid, Itaconic acid, Kojic acid, Lactic acid, Leucine, Lysine, Maleic acid, Malic acid, Methionine, Methylsalicylate, Nitrilotriacetic acid (NTA), Omithine, Orthophosphate, Oxalic acid, Oxystearin, B-Phenylalanine, Phosphoric acid, Phytate, Pimelic acid, Pivalic acid, Polyphosphate, Proline, Propionic acid, Purine, Pyrophosphate, Pyruvic acid, Riboflavin, Salicylaldehyde, Salicyclic acid, Sarcosine, Serine, Sorbitol, Succinic acid, Tartaric acid, Tetrametaphosphate, Thiosulfate, Threonine, Trimetaphosphate, Triphosphate, Tryptophan, Uridine diphosphate, Uridine triphosphate, n-Valeric acid, Valine, and Xanthosine
  • Many of the above sequestering agents are useful in food processing in their salt forms, which are commonly alkali metal or alkaline earth salts such as sodium, potassium or calcium or quaternary ammonium salts. Sequestering compounds with multiple valencies may be beneficially utilised to adjust pH or selectively introduce or abstract metal ions e.g. in a food system coating. Additional information chelators is disclosed in T. E. Furia (Ed.), CRC Handbook of Food Additives, 2nd Ed., pp. 271-294 (1972, Chemical Rubber Co.), and M. S. Peterson and A. M. Johnson (Eds.), Encyclopaedia of Food Science, pp. 694-699 (1978, AVI Publishing Company, Inc.) which articles are both hereby incorporated by reference.
  • The terms “chelator” is defined as organic or inorganic compounds capable of forming co-ordination complexes with metals. Also, as the term “chelator” is used herein, it includes molecular encapsulating compounds such as cyclodextrin. The chelator may be inorganic or organic, but preferably is organic.
  • Preferred chelator are non-toxic to mammals and include aminopolycarboxylic acids and their salts such as ethylenediaminetetraacetic acid (EDTA) or its salts (particularly its di- and tri-sodium salts), and hydrocarboxylic acids and their salts such as citric acid. However, non-citric acid and non-citrate hydrocarboxylic acid chelators are also believed useful in the present invention such as acetic acid, formic acid, lactic acid, tartaric acid and their salts.
  • As noted above, the term “chelator” is defined and used herein as a synonym for sequestering agent and is also defined as including molecular encapsulating compounds such as cyclodextrin. Cyclodextrins are cyclic carbohydrate molecules having six, seven, or eight glucose monomers arranged in a donut shaped ring, which are denoted alpha, beta or gamma cyclodextrin, respectively. As used herein, cyclodextrin refers to both unmodified and modified cyclodextrin monomers and polymers. Cyclodextrin molecular encapsulators are commercially available from American Maize-Products of Hammond, Ind. Cyclodextrin are further described in Chapter 11 entitled, “Industrial Applications of Cyclodextrin”, by J. Szejtli, page 331-390 of Inclusion Compounds, Vol. III (Academic Press, 1984) which chapter is hereby incorporated by reference.
  • Preferably the chelator enhances the antimicrobial activity and/or antimicrobial spectrum of the bacteriocin. More preferably the chelator enhances the antimicrobial activity and/or antimicrobial spectrum of the bacteriocin in respect of Gram-negative bacteria and other micro-organisms.
  • In one preferred aspect the composition further comprises a lytic enzyme. Preferably the lytic enzyme is a lysozyme.
  • Process
  • As discussed herein in one aspect the present invention provides process for preventing and/or inhibiting the growth of, and/or killing a micro-organism in a material, the process comprising the step of contacting the material with (a) an antimicrobial material; and (b) an extract obtained from or obtainable from a plant of the Labiatae family, wherein (a) and (b) are different; wherein the composition contains phenolic diterpenes in an amount of greater than 1.0 wt. %, based on the composition, and wherein when the antimicrobial material consists of nisin, the composition comprises carvacrol in an amount of less than 0.075 wt. % based on the composition and carvone in an amount of less than 15 wt. % based on the composition.
  • In one aspect the bacteriocin and the extract are added to the material together.
  • In one aspect the bacteriocin and the extract are added to the material sequentially.
  • Thus the present invention provides in one aspect a preservative/protectant composition which may be added to a range of materials such as food systems and in another aspect a combination of two separate products which may added sequentially to materials such as food products.
  • In one aspect the extract is added to the material.
  • In one aspect the bacteriocin is added to the material.
  • In one aspect the extract is formed in situ in the material.
  • In one aspect the bacteriocin is formed in situ in the material. Preferably when the bacteriocin is nisin, the bacteriocin may be formed in situ in the foodstuff by fermentation of the dairy starter culture bacterium Lactococcus lactis subsp. lactis.
  • Highly Preferred Aspects
  • As discussed herein in one aspect the present invention provides a process for preventing and/or inhibiting the growth of, and/or killing a micro-organism in a material, the process comprising the step of contacting the material with (a) an antimicrobial material; and (b) an extract obtained from or obtainable from a plant of the Labiatae family, wherein (a) and (b) are different; wherein when the antimicrobial material consists of nisin, the composition comprises carvacrol in an amount of less than 0.075 wt. % based on the composition and carvone in an amount of less than 15 wt. % based on the composition.
  • In one aspect the present invention provides use of (a) an antimicrobial material; and b) an extract obtained from or obtainable from a plant of the Labiatae family, for preventing and/or inhibiting the growth of, and/or killing a micro-organism in a material; wherein (a) and (b) are different; and wherein when the antimicrobial material consists of nisin, the composition comprises carvacrol in an amount of less than 0.075 wt. % based on the composition and carvone in an amount of less than 15 wt. % based on the composition.
  • Some highly preferred aspects of the present invention are set out below
      • a composition comprising (a) a bacteriocin, wherein the bacteriocin is nisin; and (b) an extract obtained from a plant of the Labiatae family, wherein the composition contains phenolic diterpenes in an amount of greater than 1.0 wt. %, based on the composition, and wherein the composition comprises carvacrol in an amount of less than 0.075 wt. % based on the composition and carvone in an amount of less than 15 wt. % based on the composition.
      • for preventing and/or inhibiting the growth of, and/or killing a micro-organism in a material, the process comprising the step of contacting the material with (a) a bacteriocin; wherein the bacteriocin is nisin; and (b) an extract obtained from or obtainable from a plant of the Labiatae family, wherein the composition contains phenolic diterpenes in an amount of greater than 1.0 wt. %, based on the composition, and wherein the composition comprises carvacrol in an amount of less than 0.075 wt. % based on the composition and carvone in an amount of less than 15 wt. % based on the composition.
      • use of (a) a bacteriocin, wherein the bacteriocin is nisin; and (b) an extract obtained from or obtainable from a plant of the Labiatae family, for preventing and/or inhibiting the growth of, and/or killing a micro-organism in a material, wherein the composition contains phenolic diterpenes in an amount of greater than 1.0 wt. %, based on the composition, and the composition comprises carvacrol in an amount of less than 0.075 wt. % based on the composition and carvone in an amount of less than 15 wt. % based on the composition
      • a composition comprising (a) a bacteriocin, and (b) an extract obtained from a plant of the Labiatae family selected from rosemary, sage, thyme, mint, balm, savoury and oregano, wherein (a) and (b) are different
      • a process for preventing and/or inhibiting the growth of, and/or killing a microorganism in a material, the process comprising the step of contacting the material with (a) a bacteriocin; and (b) an extract obtained from or obtainable from a plant of the Labiatae family selected from rosemary, sage, thyme, mint, balm, savoury and oregano, wherein (a) and (b) are different
      • use of (a) a bacteriocin, and (b) an extract obtained from or obtainable from a plant of the Labiatae family selected from rosemary, sage, thyme, mint, balm, savoury and oregano, for preventing and/or inhibiting the growth of, and/or killing a micro-organism in a material, wherein (a) and (b) are different
      • a composition comprising (a) a bacteriocin, and (b) a compound selected from carnosic acid, carnosol, methylcarnosic acid, betulinic acid, oleanolic acid, ursolic acid and rosmarinic acid.
      • a process for preventing and/or inhibiting the growth of, and/or killing a microorganism in a material, the process comprising the step of contacting the material with (a) a bacteriocin, and (b) a compound selected from carnosic acid, carnosol, methylcarnosic acid, betulinic acid, oleanolic acid, ursolic acid and rosmarinic acid.
      • use of (a) a bacteriocin, and (b) a compound selected from carnosic acid, carnosol, methylcarnosic acid, betulinic acid, oleanolic acid, ursolic acid and rosmarinic acid, for preventing and/or inhibiting the growth of, and/or killing a micro-organism in a material.
      • a composition comprising (a) a bacteriocin, and (b) carnosic acid.
      • a process for preventing and/or inhibiting the growth of, and/or killing a microorganism in a material, the process comprising the step of contacting the material with (a) a bacteriocin, and (b) carnosic acid.
      • use of (a) a bacteriocin, and (b) carnosic acid, for preventing and/or inhibiting the growth of, and/or killing a micro-organism in a material.
      • a composition comprising (a) a bacteriocin, wherein the bacteriocin is nisin; and (b) an extract obtained from or obtainable from a plant of the Labiatae family selected from rosemary, thyme, mint, balm, savoury, sage and oregano, wherein the composition contains phenolic diterpenes in an amount of greater than 1.0 wt. %, based on the composition, and wherein the composition comprises carvacrol in an amount of less than 0.075 wt. % based on the composition and carvone in an amount of less than 15 wt. % based on the composition.
      • a process for preventing and/or inhibiting the growth of, and/or killing a microorganism in a material, the process comprising the step of contacting the material with (a) a bacteriocin; wherein the bacteriocin is nisin; and (b) a selectively extracted extract obtained from or obtainable from a plant of the Labiatae family selected from rosemary, sage, thyme, mint, balm, savoury and oregano, wherein the composition contains phenolic diterpenes in an amount of greater than 1.0 wt. %, based on the composition, and wherein the composition comprises carvacrol in an amount of less than 0.075 wt. % based on the composition and carvone in an amount of less than 15 wt. % based on the composition.
      • use of (a) a bacteriocin, wherein the bacteriocin is nisin; and (b) a selectively extracted extract obtained from or obtainable from a plant of the Labiatae family selected from rosemary, sage, thyme, mint, balm, savoury and oregano, for preventing and/or inhibiting the growth of, and/or killing a micro-organism in a material, wherein the composition contains phenolic diterpenes in an amount of greater than 1.0 wt. %, based on the composition, and wherein the composition comprises carvacrol in an amount of less than 0.075 wt. % based on the composition and carvone in an amount of less than 15 wt. % based on the composition.
      • a composition comprising (a) a bacteriocin, wherein the bacteriocin is nisin; and (b) a compound selected from carnosic acid, carnosol, methylcarnosic acid, betulinic acid, oleanolic acid, ursolic acid and rosmarinic acid, wherein the composition contains phenolic diterpenes in an amount of greater than 1.0 wt. %, based on the composition, and wherein the composition comprises carvacrol in an amount of less than 0.075 wt. % based on the composition and carvone in an amount of less than 1 5 wt. % based on the composition.
      • a process for preventing and/or inhibiting the growth of, and/or killing a microorganism in a material, the process comprising the step of contacting the material with (a) a bacteriocin, wherein the bacteriocin is nisin; and (b) a compound selected from carnosic acid, carnosol, methylcarnosic acid, betulinic acid, oleanolic acid, ursolic acid and rosmarinic acid, wherein the composition contains phenolic diterpenes in an amount of greater than 1.0 wt. %, based on the composition, and wherein the composition comprises carvacrol in an amount of less than 0.075 wt. % based on the composition and carvone in an amount of less than 15 wt. % based on the composition.
      • use of (a) a bacteriocin, wherein the bacteriocin is nisin; and (b) a compound selected from carnosic acid, carnosol, methylcarnosic acid, betulinic acid, oleanolic acid, ursolic acid and rosmarinic acid, for preventing and/or inhibiting the growth of, and/or killing a micro-organism in a material, wherein the composition contains phenolic diterpenes in an amount of greater than 1.0 wt. %, based on the composition, and wherein the composition comprises carvacrol in an amount of less than 0.075 wt. % based on the composition and carvone in an amount of less than 15 wt. % based on the composition.
      • a composition comprising (a) a bacteriocin, wherein the bacteriocin is nisin; and (b) carnosic acid.
      • a process for preventing and/or inhibiting the growth of, and/or killing a microorganism in a material, the process comprising the step of contacting the material with (a) a bacteriocin, wherein the bacteriocin is nisin; and (b) carnosic acid.
      • use of (a) a bacteriocin, wherein the bacteriocin is nisin; and (b) carnosic acid, for preventing and/or inhibiting the growth of, and/or killing a micro-organism in a material.
      • a composition comprising (a) a bacteriocin, wherein the bacteriocin is nisin; and (b) an extract obtained from a plant of the Labiatae family selected from rosemary, sage, thyme, mint, balm, savoury and oregano, wherein the bacteriocin and the extract are present in an amount to provide a bactericidal or bacteriostatic synergistic effect, wherein the composition contains phenolic diterpenes in an amount of greater than 1.0 wt. %, based on the composition, and wherein the composition comprises carvacrol in an amount of less than 0.075 wt. % based on the composition and carvone in an amount of less than 15 wt. % based on the composition.
      • a process for preventing and/or inhibiting the growth of, and/or killing a microorganism in a material, the process comprising the step of contacting the material with (a) a bacteriocin; wherein the bacteriocin is nisin; and (b) an extract obtained from or obtainable from a plant of the Labiatae family selected from rosemary, sage, thyme, mint, balm, savoury and oregano, wherein the bacteriocin and the extract are present in an amount to provide a bactericidal or bacteriostatic synergistic effect wherein the composition contains phenolic diterpenes in an amount of greater than 1.0 wt. %, based on the composition, and wherein the composition comprises carvacrol in an amount of less than 0.075 wt. % based on the composition and carvone in an amount of less than 15 wt. % based on the composition.
      • use of (a) a bacteriocin, wherein the bacteriocin is nisin; and (b) an extract obtained from or obtainable from a plant of the Labiatae family selected from rosemary, sage, thyme, mint, balm, savoury and oregano, for preventing and/or inhibiting the growth of, and/or killing a micro-organism in a material, wherein the bacteriocin and the extract are present in an amount to provide a bactericidal or bacteriostatic synergistic effect, wherein the composition contains phenolic diterpenes in an amount of greater than 1.0 wt. %, based on the composition, and wherein the composition comprises carvacrol in an amount of less than 0.075 wt. % based on the composition and carvone in an amount of less than 15 wt. % based on the composition.
      • a composition comprising (a) a bacteriocin, wherein the bacteriocin is nisin; and (b) a compound selected from carnosic acid, carnosol, methylcarnosic acid, betulinic acid, oleanolic acid, ursolic acid and rosmarinic acid, wherein the bacteriocin and the compound are present in an amount to provide a bactericidal or bacteriostatic synergistic effect wherein the composition contains phenolic diterpenes in an amount of greater than 1.0 wt. %, based on the composition, and wherein the composition comprises carvacrol in an amount of less than 0.075 wt. % based on the composition and carvone in an amount of less than 15 wt. % based on the composition.
      • a process for preventing and/or inhibiting the growth of, and/or killing a microorganism in a material, the process comprising the step of contacting the material with (a) a bacteriocin, wherein the bacteriocin is nisin; and (b) a compound selected from carnosic acid, carnosol, methylcarnosic acid, betulinic acid, oleanolic acid, ursolic acid and rosmarinic acid, wherein the bacteriocin and the compound are present in an amount to provide a bactericidal or bacteriostatic synergistic effect wherein the composition contains phenolic diterpenes in an amount of greater than 1.0 wt. %, based on the composition, and wherein the composition comprises carvacrol in an amount of less than 0.075 wt. % based on the composition and carvone in an amount of less than 15 wt. % based on the composition.
      • use of (a) a bacteriocin, wherein the bacteriocin is nisin; and (b) a compound selected from carnosic acid, carnosol, methylcarnosic acid, betulinic acid, oleanolic acid, ursolic acid and rosmarinic acid, for preventing and/or inhibiting the growth of, and/or killing a micro-organism in a material, wherein the bacteriocin and the compound are present in an amount to provide a bactericidal or bacteriostatic synergistic effect wherein the composition contains phenolic diterpenes in an amount of greater than 1.0 wt. %, based on the composition, and wherein the composition comprises carvacrol in an amount of less than 0.075 wt. % based on the composition and carvone in an amount of less than 15 wt. % based on the composition.
      • a composition comprising (a) a bacteriocin, wherein the bacteriocin is nisin; and (b) a compound selected from carnosic acid, wherein the bacteriocin and the compound are present in an amount to provide a bactericidal or bacteriostatic synergistic effect
      • a process for preventing and/or inhibiting the growth of, and/or killing a microorganism in a material, the process comprising the step of contacting the material with (a) a bacteriocin, wherein the bacteriocin is nisin; and (b) a compound selected from carnosic acid, wherein the bacteriocin and the compound are present in an amount to provide a bactericidal or bacteriostatic synergistic effect use of (a) a bacteriocin, wherein the bacteriocin is nisin; and (b) a compound selected from carnosic acid, for preventing and/or inhibiting the growth of, and/or killing a micro-organism in a material, wherein the bacteriocin and the compound are present in an amount to provide a bactericidal or bacteriostatic synergistic effect
      • a composition comprising (a) a bacteriocin, wherein the bacteriocin is nisin; and (b) an extract obtained from a plant of the Labiatae family, wherein the composition contains phenolic diterpenes in an amount of greater than 1.0 wt. %, based on the composition, wherein the composition comprises carvacrol in an amount of less than 0.04 wt. % based on the composition and carvone in an amount of less than 0.04.% based on the composition.
      • a process for preventing and/or inhibiting the growth of, and/or killing a microorganism in a material, the process comprising the step of contacting the material with (a) a bacteriocin; wherein the bacteriocin is nisin; and (b) an extract obtained from or obtainable from a plant of the Labiatae family, wherein the composition contains phenolic diterpenes in an amount of greater than 1.0 wt. %, based on the composition, wherein the composition comprises carvacrol in an amount of less than 0.04 wt. % based on the composition and carvone in an amount of less than 0.04.% based on the composition.
      • use of (a) a bacteriocin, wherein the bacteriocin is nisin; and (b) an extract obtained from or obtainable from a plant of the Labiatae family, for preventing and/or inhibiting the growth of, and/or killing a micro-organism in a material, wherein the composition contains phenolic diterpenes in an amount of greater than 1.0 wt. %, based on the composition, wherein the composition comprises carvacrol in an amount of less than 0.04 wt. % based on the composition and carvone in an amount of less than 0.04.% based on the composition.
  • Further broad aspects of the present invention are defined below:
      • a composition comprising (a) an antimicrobial material; and (b) an extract obtained from or obtainable from a plant of the Labiatae family, wherein (a) and (b) are different; wherein the composition contains phenolic diterpenes in an amount of greater than 1.0 wt. %, based on the composition.
      • a process for preventing and/or inhibiting the growth of, and/or killing a microorganism in a material, the process comprising the step of contacting the material with (a) an antimicrobial material; and (b) an extract obtained from or obtainable from a plant of the Labiatae family, wherein (a) and (b) are different; wherein the composition contains phenolic diterpenes in an amount of greater than 1.0 wt. %.
      • use of (a) an antimicrobial material; and b) an extract obtained from or obtainable from a plant of the Labiatae family, for preventing and/or inhibiting the growth of, and/or killing a micro-organism in a material; wherein (a) and (b) are different; wherein the composition contains phenolic diterpenes in an amount of greater than 1.0 wt. %.
      • a kit for preparing a composition as defined herein, the kit comprising (a) an antimicrobial material; and (b) an extract obtained from or obtainable from a plant of the Labiatae family, wherein (a) and (b) are different; wherein the composition contains phenolic diterpenes in an amount of greater than 1.0 wt. %, based on the composition.
      • a composition comprising (a) an antimicrobial material; and (b) an extract obtained from or obtainable from a plant of the Labiatae family, wherein (a) and (b) are different; wherein when the antimicrobial material consists of nisin, the composition comprises carvacrol in an amount of less than 0.075 wt. % based on the composition and carvone in an amount of less than 15 wt. % based on the composition.
      • a process for preventing and/or inhibiting the growth of, and/or killing a microorganism in a material, the process comprising the step of contacting the material with (a) an antimicrobial material; and (b) an extract obtained from or obtainable from a plant of the Labiatae family, wherein (a) and (b) are different; wherein when the antimicrobial material consists of nisin, the composition comprises carvacrol in an amount of less than 0.075 wt. % based on the composition and carvone in an amount of less than 15 wt. % based on the composition.
      • use of (a) an antimicrobial material; and b) an extract obtained from or obtainable from a plant of the Labiatae family, for preventing and/or inhibiting the growth of, and/or killing a micro-organism in a material; wherein (a) and (b) are different; wherein when the antimicrobial material consists of nisin, the composition comprises carvacrol in an amount of less than 0.075 wt. % based on the composition and carvone in an amount of less than 1 5 wt. % based on the composition.
      • a kit for preparing a composition as defined herein, the kit comprising (a) an antimicrobial material; and (b) an extract obtained from or obtainable from a plant of the Labiatae family, wherein (a) and (b) are different; wherein when the antimicrobial material consists of nisin, the composition comprises carvacrol in an amount of less than 0.075 wt. % based on the composition and carvone in an amount of less than 15 wt. % based on the composition, in separate packages or containers; optionally with instructions for admixture and/or contacting and/or use.
  • The present invention will now be described in further detail by way of example only with reference to the accompanying figures in which:
  • FIG. 1 is a graph showing synergistic enhancement of nisin cidal activity against Listeria monocytogenes in chicken soup at 25° C. by a selectively extracted rosemary extract
  • FIG. 2 is a graph showing synergistic enhancement of nisin control of Listeria monocytogenes growth in chilled chicken soup by a selectively extracted rosemary extract (GRE09)
  • FIG. 3 is a graph showing synergistic enhancement by a selectively extracted rosemary extract of nisin control of B. cereus spore outgrowth in chilled chicken soup. Minimal detection limit was 100 cfu/g. For the length of the testing period, the samples containing the combination of nisin and rosemary had Bacillus counts at or below 100 cfu/g.
  • FIG. 4 is a graph showing combined effect of nisin, selectively extracted rosemary extracts and rosemary extract components against L. monocytogenes in chicken soup at 20° C. (Minimum detection limit 100 cfu/g)
  • FIG. 5 is a graph showing synergistic enhancement of nisin activity by selectively extracted extracts of rosemary or rosmarinic acid against Listeria monocytogenes in a chicken soup at ambient temperature.
  • FIG. 6 is a graph showing a demonstration of synergy between nisin and phenolic diterpene-containing rosemary extract. Inhibition of L. monocytogenes at 8° C.
  • FIG. 7 is a graph showing a demonstration of synergy between nisin and phenolic diterpene-containing rosemary extract. Inhibition of B. cereus at 15° C.
  • FIG. 8 is a graph showing enhanced nisin growth inhibitory activity by a phenolic diterpene-containing rosemary extract. Control of L. monocytogenes in carbonara sauce at 8° C.
  • FIG. 9 is a graph showing enhanced nisin growth inhibitory activity by a phenolic diterpene-containing rosemary extract. Control of B. cereus spores in carbonara sauce at 15° C.
  • FIG. 10 is a graph showing enhanced cidal effect of a nisin and phenolic diterpene-containing rosemary extract against L. monocytogenes in chicken soup at 20° C. a) pH 4.5
  • FIG. 11 is a graph showing enhanced cidal effect of a nisin and phenolic diterpene-containing rosemary extract against L. monocytogenes in chicken soup at 20° C. b) pH 6.7
  • The present invention will now be described in further detail in the following examples.
    • EXAMPLES
  • Experimental Evidence of Benefit
  • In vitro studies described herein have shown synergy between nisin and extracts of Rosmarinus officinalis containing >3.5% phenolic diterpenes, increasing the efficacy of nisin significantly. This enhanced activity was also observed in food models, increasing nisin kill and growth control of Gram-positive bacteria. The experimental studies also demonstrated that the phenolic diterpenes carnosic acid and carnosol were implicated in this synergy. The results also indicated that rosmarinic acid may also enhance nisin activity, although this synergistic effect was not as strong as that observed with the phenolic diterpenes.
  • I) In vitro Demonstration of Nisin and Deodorised Rosemary Extract Synergy
  • Materials: GUARDIAN™ Rosemary Extract 09 (Danisco) (GRE09). This is a water dispersible deodorised rosemary extract containing 4% phenolic diterpenes and <1% essential oils, extracted from rosemary leaves, combined with the carriers polyoxyethylene sorbitan monooleate (Tween 80) and propylene glycol. A commercial extract of nisin at potency of 1×106 IU/g: Nisaplin® Natural Antimicrobial (Danisco).
  • Test strains: Bacillus cereus 204, B. cereus Campden, B. cereus NCTC2599, B. subtilis Campden, Listeria monocytogenes 272, L. monocytogenes NCTC12426, L. monocytogenes S23, Lactobacillus sake 272, Escherichia coli S15, E. coli CRA109, Salmonella Typhimurium S29, Pseudomonas fluorescens 3756.
  • Method of microbial growth curve analysis. A 100,000 ppm GRE09 solution was prepared in water and filter sterilised (0.2 μm). Further dilutions were prepared in sterile deionised water at 1,250-20,000 ppm. Brain Heart Infusion broth (Oxoid) was prepared and GRE09 stock solutions were added to give the following test solutions of GRE09; 125, 250, 500, 750, 1000, 1250, 1500, 2000 ppm. A 10,000 IU/ml nisin solution was prepared, filter sterilised and a range of stock solutions then prepared. A range of nisin concentrations was then prepared in Brain Heart Infusion broth. A fully automated microbial growth analyser was used to determine microbial growth curves (Microbiology Reader Bioscreen C analyser linked to a PC with installed software BioLink v 5.30; Labsystem Oy, Finland). Tests were prepared in honeycomb 2 (HC 2) microtitre/cuvette plates with a capacity of 100 wells per plate. The wells were loaded with 270 μl of the prepared media and inoculated at a level of 103 CFU (colony forming units)/ml with 30 μl of microbial suspension. Incubation time and temperature was as appropriate for the test organism. This test allowed suitable test levels for the compounds to be determined. The rosemary extract and nisin were then tested in combination, using the same procedure. Nisin solutions were prepared at 50-1000 IU/ml in broth as above. GRE09 solutions were prepared at 250, 500 and 1000 ppm as above. Combinations of all these test levels were prepared and tested in the Bioscreen as before.
  • Results: The minimum inhibitory concentration of nisin alone, rosemary extract GRE09 alone and the two in combination in the Bioscreen after 48 h at 30° C. is shown in Table 1. The minimal inhibition was taken as the lowest concentration that caused total inhibition of the bacteria after 48 h at 30° C. Synergy was observed between nisin and the rosemary extract GRE09 against all Gram-positive bacteria but no significant effect was observed against Gram-negative bacteria. This can be determined from the table by comparing the column of data showing MIC levels of nisin alone, GRE09 alone and the two combined. The latter column gave levels much lower than the other two for Gram-positive bacteria (Bacillus, Listeria) but not for Gram-negative bacteria (E. coli, Salmonella).
    TABLE 1
    Synergy tests of nisin and the rosemary extract GRE09
    Other test levels of the
    MIC in broth after 48 h at 30° C. (total combination causing total
    inhibition) inhibition
    Nisin GRE09 MIC of nisin
    Test organism (IU/ml) (ppm) (IU/ml) + GRE09 (ppm) Nisin (IU/ml) + GRE09 (ppm)
    B. cereus 204  500 >1000 50 + 250  50 + 500
     50 + 1000
    100 + 250
    100 + 500
     100 + 1000
    200 + 250
    200 + 500
     200 + 1000
    B. cereus  500 >1000 50 + 250  50 + 500
    NCTC2599  50 + 1000
    100 + 250
    100 + 500
     100 + 1000
    200 + 250
    200 + 500
     200 + 1000
    B. subtilis  100 >1000 50 + 250  50 + 500
    Campden  50 + 1000
    100 + 250
    100 + 500
     100 + 1000
    200 + 250
    200 + 500
     200 + 1000
    L. >500 >1000 50 + 250  50 + 500
    monocytogenes  50 + 1000
    S23 100 + 250
    100 + 500
     100 + 1000
    200 + 250
    200 + 500
     200 + 1000
    L. >500 >1000 50 + 250  50 + 500
    monocytogenes  50 + 1000
    272 100 + 250
    100 + 500
     100 + 1000
    200 + 250
    200 + 500
     200 + 1000
    L. >500 >1000 50 + 250  50 + 500
    monocytogenes  50 + 1000
    12426 100 + 250
    100 + 500
     100 + 1000
    200 + 250
    200 + 500
     200 + 1000
    E. coli S15 >500 >1000  >1000 + >1000  —
    E. coli CRA109 >500 >1000  >1000 + >1000  —
    S. Typhimurium >500 >1000  >1000 + >1000  —
    S29
    Ps. fluorescens >500 >1000  >1000 + >1000  —
    3756

    II) Demonstration of Nisin and Rosemary Extract GRE09 Synergy in Food
    A) Synergy Against Listeria monocytogenes
  • Test compounds: GRE09 at 0.1%, 0.5%, Nisaplin® (Danisco).
  • Test strains: a cocktail was prepared of L. monocytogenes strains NCTC12426, NCTC5105, NCC FSM60 and CRA3930. The Listeria strains were grown at 30° C. on Brain heart infusion agar overnight then inoculated into broth at 30° C. overnight. A volume of each broth was mixed together to give a cocktail of strains with a cell concentration of approximately 109 CFU/ml.
  • Media: A chilled pasteurised chicken soup was used as a food model because it was a 15 good mix of different food components including vegetables, dairy products and poultry meat It was comprised of a chicken stock with the addition of chicken, cream, vegetables, flour and seasonings. The pH was 6.12. After addition of nisin and rosemary extract GRE09, the soup was pasteurised at a core temperature of 80° C. for 2 minutes. The Listeria cocktail was diluted to 104 CFU/ml and inoculated into soup tests to give a final cell count of approximately 102 CFU/g (growth inhibitory tests) and 107 CFU/ml (cidal tests). The latter test was incubated at 25° C. for 2 h and then tested by viable count enumeration to estimate the extent of cidal activity. The growth test was incubated at 8° C. with regular sampling to estimate bacteriostatic activity.
  • Results. The rosemary extract GRE09 alone at 0.5% showed no listericidal activity. Nisin at 250 IU/g caused a 1 log drop in Listeria numbers after 2 h, but only a slight delay in growth after 24 h (FIG. 1). In comparison the combination of the two test products at these levels caused a 2-3 log drop in Listeria numbers after 2 h. After 24 h the cells still had not recovered to their initial inoculum level. This was a particularly harsh test for any preservative system, since the test medium was a rich food model, the incubation temperature was at ambient and the bacterial numbers high. Therefore any enhanced nisin activity was a good indication of synergy.
  • Incubation for the bacteriostatic test was for 43 days: results of this are shown in FIG. 2 and Table 2. The nisin/rosemary synergy was again clearly demonstrated in the food model against the Listeria cocktail. For example, Listeria growth reached 106 CFU/ml after 13 days in the presence of 100 IU/ml nisin; after 10 days in the presence of 0.1% GRE09 but only after a much longer period, 34 days, in the presence of the combination of these two ingredients. Similarly, Listeria growth reached 106 CFU/ml after 13 days in the presence of 100 IU/ml nisin; after 20 days in the presence of 0.5% GRE09. The combination of the two components resulted in no growth being observed by then end of the test period.
    TABLE 2
    Summary of growth inhibition of Listeria in chilled chicken soup
    (Trial lasted 43 days)
    Days until growth
    Test conditions reached 106 CFU/ml
    Control
    6
    Nisin at 100 IU/ml 13
    Nisin at 250 IU/ml 27
    Rosemary extract GRE09 at 0.1% 10
    Rosemary extract GRE09 at 0.5% 20
    Nisin (100 IU/ml) + GRE09 at 0.1% 34
    Nisaplin (100 IU/ml) + GRE09 at 0.5% >43
    Nisaplin (250 IU/ml) + GRE09 at 0.1% >43
    Nisaplin (250 IU/ml) + GRE09 at 0.5% >43
  • During the test period (a) Nisaplin (100 IU/ml) +GRE09 at 0.5%, (b) Nisaplin (250 IU/ml)+GRE09 at 0.1%, and (c) Nisaplin (250 IU/ml)+GRE09 at 0.5% did not give any total aerobic viable counts above 100 cfu/g.
  • B) Synergy Against Bacillus cereus
  • Test strains: a cocktail of Bacillus spores was prepared as an inoculum, using Bacillus cereus strain 204, Bacillus cereus strain 199, B. cereus strain Campden, and B. cereus strain ABC 4/9.
  • Additions of the test compounds were made to chicken soup, prepared as above. The soup was pasteurised at 70° C. for 2 minutes, cooled and inoculated with approximately 103 CFU/g of a cocktail of Bacillus cereus spores. Incubation was for 56 days. Results are shown in FIG. 3 and summarised in Table 3. Bacteriostatic synergy between the nisin and rosemary extract GRE09 was evident. For example, spoilage (i.e. 106 CFU/ml) resulted after 13 days in the presence of 25 IU/ml nisin, and after 10 days in the presence of 300 ppm GRE09. In the presence of both these ingredients, no spoilage had occurred by the end of the trial (56 days).
    TABLE 3
    Summary of results of chilled chicken soup trial inoculated with
    Bacillus cereus spores (Trial lasted 70 days).
    Days until growth
    Test conditions reached 106 CFU/ml
    Control
    6
    Nisin at 25 IU/ml 13
    Rosemary extract GRE09 at 300 ppm 10
    Rosemary extract GRE09 at 600 ppm 13
    Nisin (25 IU/ml) + GRE09 at 300 ppm >70
    Nisaplin (25 IU/ml) + GRE09 at 600 ppm >70

    C) Synergy Against Clostridium sporogenes
  • Test strains: a cocktail of Clostridium spores was prepared as an inoculum, using Clostridium sporogenes strain Campden, Clostridium sporogenes 1.221, and Clostridium sporogenes NCIMB1793.
  • Additions of the test compounds were made to chicken soup, prepared as above. The soup was pasteurised at 70° C. for 2 minutes and transferred to sterile test tubes. These were inoculated with a cocktail of heat-shocked Clostridium sporogenes spores, at a level of 2.2×102 CFU/g, then anaerobic conditions were created by plugging the tubes with agar. The samples were incubated at 37° C. and checked daily for gas production (observed by blowing of the gas plug and by the distinctive clostridial odour). Results for a 27 day incubation period, demonstrating synergy, are shown in Table 4. For example, synergy was clearly seen by the combined effect of 50 IU/ml nisin and 300 ppm GRE09, which prevented growth for 27 days (the length of the trial), whereas the individual ingredients both prevented clostridial growth for 2 days (the same as the control).
    TABLE 4
    Summary of results of chicken soup trial inoculated with Clostridium
    sporogenes spores incubated at 37° C. (Trial lasted 27 days).
    Days until growth
    Test conditions observed (gas production)
    Control 2
    Nisin at 25 IU/ml 2
    Nisin at 50 IU/ml 2
    Nisin at 100 IU/ml 7
    Rosemary extract GRE09 at 300 ppm 2
    Rosemary extract GRE09 at 600 ppm 2
    Nisin (25 IU/ml) + GRE09 at 300 ppm 3
    Nisin (50 IU/ml) + GRE09 at 300 ppm >27
    Nisin (100 IU/ml) + GRE09 at 300 ppm >27
    Nisaplin (25 IU/ml) + GRE09 at 600 ppm 10
    Nisaplin (100 IU/ml) + GRE09 at 600 ppm >27

    III) Demonstration of in vitro Synergy with Different Deodorised, Selectively Extracted Rosemary Extracts and Rosmarinic Acid
  • Growth curves of Listeria monocytogenes and B. cereus strains in laboratory media were analysed as described above using the Bioscreen C analyser. Minimal inhibitory concentrations (MIC) were determined for the test compounds used singly or in combination after 24 h at 30° C. Results are shown in Table 5. The test compounds comprised nisin (as Nisaplin®; Danisco), GRE09 (Danisco), pure rosmarinic acid (RA; Sigma) and a range of deodorised rosemary extracts. These had been prepared by selected extraction with either organic solvents or CO2 to obtain extracts containing 28% phenolic diterpenes (28RE; Danisco) and a rosemary extract containing 6% rosmarinic acid (6RA; Danisco). Enhanced nisin activity was evident with a combination of nisin combined with pure rosmarinic acid (RA; this may have partly been due to low pH levels), a combination of nisin with a rosemary extract containing 6% rosmarinic acid (6RA) and a combination of nisin with a deodorised rosemary extract containing 28% phenolic diterpenes and <1% essential oils (28RE). The known nisin synergy with Tween 80 was also observed. The other carrier propylene glycol did not enhance nisin activity. The synergies can be observed, as before, by comparing the MIC levels for nisin alone, the other test compound, and the two together (see Table 5).
    TABLE 5
    MIC after growth at 30° C. in laboratory medium
    MIC in Bioscreen after 24 h at 30° C.
    Test organism Individual components Combination with nisin
    L. monocytogenes Nisin at 1000 IU/ml —
    strain S23 0.1% GRE09 0.05% GRE09 + 50 IU/ml
    nisin
    1% RA 0.25% RA + 250 IU/ml
    nisin
    0.5% RA + 100 IU/ml
    nisin
    0.75% RA + 50 IU/ml
    nisin
    1% 6RA <0.1% 6RA + 250 IU/ml
    nisin
    0.5% 6RA + 50 IU/ml nisin
    L. monocytogenes 500 IU/ml nisin —
    strain 272 0.25% GRE09 <0.05% GRE09 + 50
    IU/ml nisin
    1% of RE28 <0.05% RE28 + 50 IU/ml
    nisin
    >2% Tween 80 0.5% Tween 80 + 250
    IU/ml nisin
    L. monocytogenes 250 IU/ml nisin —
    strain NCTC12426 0.25% GRE09 <0.05% GR 09 + 50
    IU/ml nisin
    1% of RE28 <0.05% RE28 + 50 IU/ml
    nisin
    >2% Tween 80 0.5% Tween 80 + 100
    IU/ml nisin
    B. cereus 500 IU/ml nisin —
    Campden spores 0.1% GRE09 0.05% GRE09 + 50 IU/ml
    1% RA 0.5% RA + 250 IU/ml
    nisin
    0.75% RA + 100 IU/ml
    nisin
    0.75% RA + 50 IU/ml
    nisin
    1% 6RA 0.25% 6RA + 100 IU/ml
    nisin
    0.5% 6RA + 50 IU/ml
    nisin

    IV) Demonstration of Synergy for Nisin Activity with Different Deodorised Rosemary Extract Components in Food
  • Test strains: Listeria monocytogenes strains 272, CRA3930 and NCTC12426
  • The chicken soup model was used as before. The following samples were tested: GRE09, deodorised rosemary extracts containing 28% or 70% phenolic diterpenes (RE28 and RE70; Danisco), a water soluble rosemary extract containing 6% rosmarinic acid (6RA; Danisco) and pure rosmarinic acid (RA; Sigma). Additions to the soup were made as appropriate. The soup was pasteurised (70° C./2 minutes), the pH recorded and the soup was then inoculated with a cocktail of Listeria cells prepared as described before. The tests were incubated at 20° C. and viable count enumeration performed after 0, 2, 4 and 24 h at 20 ° C. Initial Listeria levels were 1.3×105 CFU/ml. The test was repeated at two nisin levels and over different time periods. The pH of the soup without addition was pH 6.06-6.20. Addition of rosmarinic acid at 0.1% resulted in a slight pH drop to pH 5.75. Addition of 6% RA resulted in a soup pH of pH 5.75-5.78. Addition of 0.5% RE28 resulted in a soup pH of pH 5.98. Addition of 0.5% RE70 resulted in a soup pH of pH 6.10. Addition of 0.5% GRE09 resulted in a soup pH of pH 6.02-6.09.
  • Results, shown in FIGS. 4 and 5, indicate that all the deodorised extracts tested and rosmarinic acid contributed to synergy with nisin in achieving kill of Listeria cells. This could not be attributed to the drop in pH caused by some of the additions. The additional synergy with Tween 80 was observed in GRE09. The results indicate that the antioxidant compounds carnosol and carnosic acid, present at 28 and 70% in two of the extracts tested, synergistically enhanced the cidal and growth inhibitory activity of nisin against Listeria monocytogenes. A nisin synergy with rosmarinic acid was evident but not as strong.
  • V) Demonstration of Synergistic Enhancement of Nisin's Growth Inhibitory Activity in Different Food Systems Using a Blend of Nisin with a Phenolic Diterpene-Containing Rosemary Extract
  • A) Pasteurised Chicken Soup Tests
  • Method: Different additions of nisin (as Nisaplin®, Danisco), a Rosemary extract containing 28% phenolic diterpenes (RE28), and a blend of nisin with the Rosemary extract at levels of 50 IU/mg and 4.2% phenolic diterpenes were added to commercial chicken soup that contained no other preservatives. After addition of the compounds the soup (pH 5.8) was pasteurised at a core temperature of 70° C. for 2 minutes. The soup was cooled to ambient temperature and either inoculated with a cocktail of stationary phase cells of Listeria monocytogenes strains or spores of Bacillus cereus. The strain cocktails comprised: L. monocytogenes strains NCIMB12426, strain 358, strain 272, strain CRA3930. The B. cereus cocktail comprised strains 204, 199, ABC4/9 and 3.046. Initial inoculum levels were approximately 102-103 CFU/g. Bacillus tests were incubated at 15° C., Listeria tests were incubated at 8° C. Microbiological analysis was conducted at regular intervals (Milk Plate count Agar, Oxford Listeria Selective agar).
  • Results: The results, shown as the time taken for bacterial numbers to reach 106 CFU/g, are summarised in Table 5. The full data are shown in FIGS. 6 and 7. The results show that the Rosemary extract alone had no activity against Bacillus, and only slight activity against Listeria. The Rosemary extract significantly enhanced the growth inhibitory activity of nisin.
    TABLE 5
    Summary of results demonstrating nisin/phenolic diterpene synergy
    against Listeria and Bacillus in a pasteurised chicken soup
    Days until growth reached
    Phenolic 106 CFU/g
    Nisin diterpene L. monocytogenes B. cereus
    Test content content at 8° C. at 15° C.
    Control
    0    3 2
    RE28 at 75 ppm  0 IU/g 21 ppm 5 2
    Nisaplin at 100 IU/g 0 ppm 6 3
    100 mg/kg
    Nisaplin at 250 IU/g 0 ppm 16 6
    250 mg/kg
    Nisin/Rosemary 100 IU/g 8.4 pm 15 >26
    blend A
    Nisin/Rosemary 250 IU/g 21 ppm 52 >26
    blend B

    B) Pasteurised Meat Pasta Sauce Tests
  • Method: The sauce was prepared from lean minced beef (50%), tomatoes and juice (48.9%), starch (0.5%), saKt (0.4%) and sucrose (0.2%). The beef was fried for 5 minutes until brown, then the dry ingredients mixed in followed by the tomatoes with juice. The sauce was simmered for 10 minutes and allowed to cool before blending to a smooth consistency. Final pH was 5.13. Additions were made of nisin, rosemary extract and blends. The sauce was pasteurised to a core temperature of 80° C. for 2 minutes. A cocktail of Listeria monocytogenes strains (as above) were inoculated after pasteurisation and the tests incubated at 8° C.
  • Results: The results, shown as the time taken for bacterial numbers to reach 106 CFU/g, are summarised in Table 6. These show that the rosemary extract alone had no activity against Bacillus, and only slight activity against Listeria. The rosemary extract significantly enhanced the growth inhibitory activity of nisin.
    TABLE 6
    Summary of results demonstrating nisin/phenolic diterpene synergy
    against Listeria in a pasteurised meat sauce at 8° C.
    Phenolic Days until 106
    Test Nisin diterpene CFU/g
    Control
    0 0 4
    RE28 at 60 ppm 0 IU/g 16.8 ppm 5
    Nisaplin at 100 mg/kg 100 IU/g 0 ppm 11
    Nisin/Rosemary blend A 100 IU/g 8.4 pm >76

    C) Carbonara Pasta Sauce Tests
  • Method: A commercial chilled pasteurised sauce was used, containing cream, smoked bacon, cheese, mascarpone, butter, starch, onion, garlic puree. Protein 7 g, carbohydrate 6 g, fat 17 g. Additions of test compounds were made prior to the pasteurisation (core temperature of 70° C. for 10 minutes). Inoculations were made once the sauce had cooled. Samples were analysed regularly for microbial numbers.
  • Results: These are shown in FIGS. 8 and 9. As before, the phenolic diterpene-containing extract (8.4 ppm) synergistically enhanced the nisin growth inhibitory activity against Listeria cells and Bacillus spores. The rosemary extract alone showed no activity.
  • VI) Demonstration of Synergistic Enhancement of Nisin's Cidal Activity in a Food System Using a Blend of Nisin with Phenolic Diterpene-Containing Rosemary Extract
  • Method: The diluted chicken soup (pH 6.2) was prepared as above, and split into 2 batches with one batch being adjusted to pH 4.5 with HCl. Appropriate additions of nisin, rosemary extract and blends were made, then the soup was pasteurised. A cocktail of Listeria strains was inoculated to give an initial inoculum of 105 CFU/g. Viable cells were enumerated by microbiological analysis at 0 and 2 h.
  • The test blends contained 1) 100 IU/g nisin+30 ppm rosemary extract (i.e. 8.4 phenolic diterpenes), and 2) 150 IU/g nisin+45 ppm rosemary extract (i.e. 12.6 phenolic diterpenes).
  • Results: The results demonstrated that the presence of the phenolic diterpene containing rosemary extract synergistically enhanced the cidal activity of nisin (FIGS. 10 and 11), particularly at more acidic conditions (FIG. 10). The rosemary extract alone had no significant cidal effect.

Claims (67)

1. A composition comprising
(a) an antimicrobial material; and
(b) an extract obtained from or obtainable from a plant of the Labiatae family,
wherein (a) and (b) are different
wherein the composition contains phenolic diterpenes in an amount of greater than 1.0 wt. %, based on the composition,
and wherein when the antimicrobial material consists of nisin, the composition comprises carvacrol in an amount of less than 0.075 wt. % based on the composition and carvone in an amount of less than 15 wt. % based on the composition.
2. A composition according to claim 1 wherein the composition comprises carvacrol in an amount of less than 0.075 wt. % based on the composition.
3. A composition according to claim 1 or 2 wherein the composition comprises carvacrol in an amount of less than 0.04 wt. % based on the composition.
4. A composition according to claim 1, 2 or 3 wherein the composition comprises carvacrol in an amount of less than 0.02 wt. % based on the composition.
5. A composition according to any one of the preceding claims wherein the composition comprises carvone in an amount of less than 0.075 wt. % based on the composition.
6. A composition according to any one of the preceding claims wherein the composition comprises carvone in an amount of less than 0.04 wt. % based on the composition.
7. A composition according to any one of the preceding claims wherein the composition comprises carvone in an amount of less than 0.02 wt. % based on the composition.
8. A composition according to any one of the preceding claims wherein the composition comprises thymol in an amount of less than 0.1 wt. % based on the composition.
9. A composition according to any one of the preceding claims wherein the composition comprises thymol in an amount of less than 0.075 wt. % based on the composition.
10. A composition according to any one of the preceding claims wherein the composition comprises thymol in an amount of less than 0.05 wt. % based on the composition.
11. A composition according to any one of the preceding claims wherein the antimicrobial material is a bacteriocin.
12. A composition according to any one of the preceding claims wherein the bacteriocin is selected from lanthionine containing bacteriocins, Lactococcus-derived bacteriocins, Streptococcus-derived bacteriocins, Pediococcus-derived bacteriocins, Lactobacillus-derived bacteriocins, Carnobacterium-derived bacteriocins, Leuconostoc-derived bacteriocins, Enterococcus-derived bacteriocins and mixtures thereof
13. A composition according to any one of the preceding claims wherein the bacteriocin is at least nisin.
14. A composition according to any one of the preceding claims wherein the extract is obtained from a plant of the Labiatae family.
15. A composition according to any one of the preceding claims wherein the plant of the Labiatae family is selected from rosemary, sage, oregano, marjoram, mint, balm, savoury, and thyme.
16. A composition according to any one of the preceding claims wherein the plant of the Labiatae family is selected from rosemary, sage, oregano, marjoram, mint, balm, and savoury.
17. A composition according to any one of the preceding claims wherein the plant of the Labiatae family is rosemary.
18. A composition according to any one of the preceding claims wherein the composition contains phenolic diterpenes in an amount of is greater than 2.0 wt. %, based on the composition.
19. A composition according to any one of the preceding claims wherein the composition contains phenolic diterpenes in an amount of is greater than 3.0 wt. %, based on the composition.
20. A composition according to any one of the preceding claims wherein the composition contains phenolic diterpenes in an amount of is greater than 3.5 wt. %, based on the composition.
21. A composition according to any one of the preceding claims wherein the phenolic diterpene is selected from carnosic acid, carnosol, methylcarnosic acid and mixtures thereof.
22. A composition according to any one of the preceding claims wherein the extract comprises or is selected from phenolic diterpenes, phenolic triterpenes and rosmarinic acid.
23. A composition according to any one of the preceding claims wherein the extract comprises a phenolic triterpene.
24. A composition according to claim 17 wherein the amount of phenolic triterpenes, based on the composition, is greater than 3.5 wt. %.
25. A composition according to claim 16, 17 or 18 wherein the phenolic triterpene is selected from betulinic acid, oleanolic acid, and ursolic acid.
26. A composition according to any one of the preceding claims wherein the extract comprises a rosmarinic acid.
27. A composition according to claim 20 wherein the amount of rosmarinic acid, based on the composition, is greater than 3.5 wt. %.
28. A composition according to any one of the preceding claims wherein the combined amount of phenolic diterpenes, phenolic triterpenes and rosmarinic acid, based on the composition, is greater than 3.5 wt. %.
29. A composition according to any one of the preceding claims wherein the extract contains flavour-inducing compounds and/or essential oils in an amount of less than 1 wt. % based on the composition.
30. A composition according to any one of the preceding claims wherein the extract contains essential oils in an amount of less than 1 wt. % based on the composition.
31. A composition according to any one of the preceding claims wherein the antimicrobial material and/or the extract are present in an amount to provide a microbicidal or microbiostatic effect.
32. A composition according to any one of the preceding claims wherein the antimicrobial material and the extract are present in an amount to provide a microbicidal or microbiostatic effect.
33. A composition according to any one of the preceding claims wherein the antimicrobial material and the extract are present in an amount to provide a microbicidal or microbiostatic synergistic effect.
34. A composition according to any one of the preceding claims wherein the antimicrobial material and the extract are present in an amount to provide a microbicidal synergistic effect.
35. A composition according to any one of claims 31 to 34 wherein the microbicidal or microbiostatic effect is a bactericidal or bacteriostatic effect.
36. A composition according to claim 35 wherein the bactericidal or bacteriostatic effect is in respect of Gram-positive bacteria.
37. A composition according to claim 36 wherein the bactericidal or bacteriostatic effect is in respect of an organism selected from species of Bacillus, species of Clostridium, Listeria monocytogenes, lactic acid bacteria, and Lactobacillus species.
38. A composition according to any one of claims 35 to 37 wherein the bactericidal or bacteriostatic effect is in respect of Listeria monocytogenes.
39. A composition according to any one of the preceding claims wherein the composition is a foodstuff.
40. A composition according to any one of the preceding claims wherein the composition is a protectant composition suitable for addition to a foodstuff.
41. A composition according to claim 39 or 40 the foodstuff is selected from raw meat, cooked meat, raw poultry products, cooked poultry products, raw seafood products, cooked seafood products, ready to eat meals, pasta sauces, pasteurised soups, mayonnaise, salad dressings, oil-in-water emulsions, margarines, low fat spreads, water-in-oil emulsions, dairy products, cheese spreads, processed cheese, dairy desserts, flavoured milks, cream, fermented milk products, cheese, butter, condensed milk products, ice cream mixes, soya products, pasteurised liquid egg, bakery products, confectionery products, fruit products, and foods with fat-based or water-containing fillings.
42. A composition according to any one of the preceding claims wherein the composition further comprises an emulsifier.
43. A composition according to claim 42 wherein the emulsifier is selected from polysorbates, monoglycerides, diglycerides, acetic acid esters of mono-diglycerides, tartaric acid esters of mono-diglycerides and citric acid esters of mono-diglycerides.
44. A composition according to any one of the preceding claims wherein the composition further comprises a chelator.
45. A composition according to claim 44 wherein the chelator is selected from EDTA, citric acid, monophosphates, diphosphates, triphosphates and polyphosphates.
46. A composition according to claim 44 or 45 wherein the chelator enhances the antimicrobial activity and/or antimicrobial spectrum of the antimicrobial material.
47. A composition according to claim 44, 45 or 46 wherein the chelator enhances the antimicrobial activity and/or antimicrobial spectrum of the antimicrobial material in respect of Gram-negative bacteria.
48. A composition according to any one of the preceding claims wherein the composition further comprises a lytic enzyme.
49. A composition according to claim 48 wherein the lytic enzyme is a lysozyme.
50. A composition according to claim 1 comprising
(a) an antimicrobial material, wherein the antimicrobial material is nisin; and
(b) an extract obtained from a plant of the Labiatae family, wherein the extract is a phenolic triterpene selected from betulinic acid, oleanolic acid or ursolic acid wherein the antimicrobial material and the extract are present in an amount to provide a bactericidal or bacteriostatic synergistic effect.
51. A composition according to claim 1 comprising
(a) an antimicrobial material, wherein the antimicrobial material is nisin; and
(b) an extract obtained from a plant of the Labiatae family, wherein the extract is rosmarinic acid,
wherein the antimicrobial material and the extract are present in an amount to provide a bactericidal or bacteriostatic synergistic effect.
52. A process for preventing and/or inhibiting the growth of, and/or killing a microorganism in a material, the process comprising the step of contacting the material with
(a) an antimicrobial material; and
(b) an extract obtained from or obtainable from a plant of the Labiatae family,
wherein (a) and (b) are different
wherein the composition contains phenolic diterpenes in an amount of greater than 1.0 wt. %, based on the composition,
wherein when the antimicrobial material consists of nisin, the composition comprises carvacrol in an amount of less than 0.075 wt. % based on the composition and carvone in an amount of less than 15 wt. % based on the composition.
53. A process according to claim 52 wherein the antimicrobial material and the extract are added to the material together.
54. A process according to claim 52 wherein the antimicrobial material and the extract are added to the material sequentially.
55. A process according to any one of claims 52 to 54 wherein the bacteriocin is added to the material.
56. A process according to claim 52 wherein the bacteriocin is formed in situ in the material.
57. A process according to any one of claims 52 to 56 wherein the material is a foodstuff.
58. A process according to any one of claims 52 to 57 characterised by the features of any one of claim 2 to 51.
59. Use of (a) an antimicrobial material; and b) an extract obtained from or obtainable from a plant of the Labiatae family, for preventing and/or inhibiting the growth of, and/or killing a micro-organism in a material; wherein (a) and (b) are different; wherein the composition contains phenolic diterpenes in an amount of greater than 1.0 wt. %, based on the composition, and wherein when the antimicrobial material consists of nisin, the composition comprises carvacrol in an amount of less than 0.075 wt. % based on the composition and carvone in an amount of less than 15 wt. % based on the composition.
60. Use according to claim 59 wherein the material is a foodstuff.
61. Use according to claim 59 or 60 for synergistically preventing and/or inhibiting the growth of, and/or killing a micro-organism in a material.
62. Use according to any one of claims 59 to 61 characterised by the features of any one of claim 2 to 51.
63. A kit for preparing a composition as defined in any one of claims 1 to 51, the kit comprising
(a) an antimicrobial material; and
(b) an extract obtained from or obtainable from a plant of the Labiatae family,
wherein (a) and (b) are different
in separate packages or containers; optionally with instructions for admixture and/or contacting and/or use.
64. A composition as substantially hereinbefore described with reference to any one of the Examples.
65. A process as substantially hereinbefore described with reference to any one of the Examples.
66. A use as substantially hereinbefore described with reference to any one of the Examples.
67. A kit as substantially hereinbefore described with reference to any one of the Examples.
US10/568,324 2003-08-22 2004-08-06 Composition comprising a bacteriocin and an extract from a plant of the labiatae family Abandoned US20070104809A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US10/568,324 US20070104809A1 (en) 2003-08-22 2004-08-06 Composition comprising a bacteriocin and an extract from a plant of the labiatae family

Applications Claiming Priority (10)

Application Number Priority Date Filing Date Title
US49740903P 2003-08-22 2003-08-22
GB0319817.3 2003-08-22
GB0319817A GB2388581A (en) 2003-08-22 2003-08-22 Coated aqueous beads
GB0323335A GB0323335D0 (en) 2003-10-06 2003-10-06 Composition
GB0323335.0 2003-10-06
US53305303P 2003-12-30 2003-12-30
US56027004P 2004-04-08 2004-04-08
US10/820,147 US20050042341A1 (en) 2003-08-22 2004-04-08 Natamycin dosage form, method for preparing same and use thereof
US10/568,324 US20070104809A1 (en) 2003-08-22 2004-08-06 Composition comprising a bacteriocin and an extract from a plant of the labiatae family
PCT/GB2004/003423 WO2005018333A1 (en) 2003-08-22 2004-08-06 Composition comprising a bacteriocin and an extract from a plant of the labiatae family

Related Parent Applications (2)

Application Number Title Priority Date Filing Date
US10/820,147 Continuation-In-Part US20050042341A1 (en) 2003-08-22 2004-04-08 Natamycin dosage form, method for preparing same and use thereof
PCT/GB2004/003423 A-371-Of-International WO2005018333A1 (en) 2003-08-22 2004-08-06 Composition comprising a bacteriocin and an extract from a plant of the labiatae family

Related Child Applications (1)

Application Number Title Priority Date Filing Date
US14/974,437 Continuation US10271557B2 (en) 2003-08-22 2015-12-18 Composition comprising a bacteriocin and an extract from a plant of the Labiatae family

Publications (1)

Publication Number Publication Date
US20070104809A1 true US20070104809A1 (en) 2007-05-10

Family

ID=37767637

Family Applications (3)

Application Number Title Priority Date Filing Date
US10/568,324 Abandoned US20070104809A1 (en) 2003-08-22 2004-08-06 Composition comprising a bacteriocin and an extract from a plant of the labiatae family
US10/568,661 Abandoned US20070042184A1 (en) 2003-08-22 2004-08-06 Microcapsules
US14/974,437 Expired - Lifetime US10271557B2 (en) 2003-08-22 2015-12-18 Composition comprising a bacteriocin and an extract from a plant of the Labiatae family

Family Applications After (2)

Application Number Title Priority Date Filing Date
US10/568,661 Abandoned US20070042184A1 (en) 2003-08-22 2004-08-06 Microcapsules
US14/974,437 Expired - Lifetime US10271557B2 (en) 2003-08-22 2015-12-18 Composition comprising a bacteriocin and an extract from a plant of the Labiatae family

Country Status (4)

Country Link
US (3) US20070104809A1 (en)
JP (1) JP4926707B2 (en)
DK (1) DK1656026T3 (en)
ES (1) ES2481167T3 (en)

Cited By (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100160224A1 (en) * 2008-10-14 2010-06-24 David Thomas Shelf-stable consumable compositions containing probiotic-mimicking elements and methods of preparing and using the same
US20110151034A1 (en) * 2008-08-04 2011-06-23 Mitsubishi Chemical Corporation Antibacterial agent and disinfecting method
WO2012142077A3 (en) * 2011-04-11 2014-05-01 Kemin Industries, Inc. Use of propionic acid as an antimicrobial
US20160157482A1 (en) * 2013-05-07 2016-06-09 Kemin Industries, Inc. Antimicrobial Compositions Containing Carvacrol and Thymol
WO2016128508A1 (en) * 2015-02-11 2016-08-18 Chr. Hansen A/S Reduction of the concentration of gram-negative bacteria in a fermented food product by the combination of red wine extract and a culture comprising at least one bacteriocin-producing lactic acid bacterial strain
US10159268B2 (en) 2013-02-08 2018-12-25 General Mills, Inc. Reduced sodium food products
CN111389315A (en) * 2020-03-27 2020-07-10 南京芬之怡生物科技有限公司 Green impurity-removing purifying agent and preparation method thereof
US20220039412A1 (en) * 2009-10-15 2022-02-10 Dupont Nutrition Biosciences Aps Anti-oxidant composition
US11793223B2 (en) 2018-03-09 2023-10-24 Conopco Inc. Antioxidant composition
US11930833B2 (en) 2017-02-14 2024-03-19 Kraft Foods Group Brands Llc Process for maintaining freshness of vegetable pieces

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050214370A1 (en) * 2004-03-26 2005-09-29 Sarama Robert J Stable coating agent comprising sterol
EP2142293A2 (en) * 2007-04-26 2010-01-13 Basf Se Enzymatic method for the production of microcapsules
US20090095164A1 (en) * 2007-05-17 2009-04-16 Salvatore Albert Celeste Method of enhancing beverages by means of a unique microencapsulated delivery system
US11039707B2 (en) 2007-05-17 2021-06-22 International Flavors & Fragrances Inc. Microencapsulated delivery system
IL183818A0 (en) * 2007-06-10 2007-10-31 Shimon Harpaz Uniformly abrasive confectionery product and process therefor
WO2009006466A1 (en) * 2007-07-02 2009-01-08 Novus International Inc. Feeding regime for prevention of porcine enteropathic conditions
WO2009023014A1 (en) * 2007-08-13 2009-02-19 Alpharma, Inc. Emamectin compositions and methods
US20090104251A1 (en) * 2007-10-22 2009-04-23 Sensient Flavors Inc. Heat stable microcapsules and methods for making and using the same
BRPI0919589A2 (en) * 2008-10-24 2015-12-08 Basf Se processes for preparing microparticles, for combating the growth of undesirable plants, and for combating undesirable mite or insect infestation in plants and / or for combating phytopathogenic fungi, microparticle, agrochemical formulation, and seed
ES2732833T3 (en) 2009-03-26 2019-11-26 Advanced Bionutrition Corp Microencapsulation of bioactive substances and methods of obtaining it
CH701000A1 (en) * 2009-04-30 2010-11-15 U Nica Technology Ag Bacteriorhodopsin-containing microcapsules and methods for their preparation.
US8747562B2 (en) * 2009-10-09 2014-06-10 Philip Morris Usa Inc. Tobacco-free pouched product containing flavor beads providing immediate and long lasting flavor release
US8383984B2 (en) * 2010-04-02 2013-02-26 Electro Scientific Industries, Inc. Method and apparatus for laser singulation of brittle materials
US20130295012A1 (en) 2010-08-30 2013-11-07 President And Fellows Of Harvard College Shear controlled release for stenotic lesions and thrombolytic therapies
US9132291B2 (en) 2010-10-05 2015-09-15 Dfb Technology, Ltd. Water-in-oil emulsion compositions containing gellan gum for topical delivery of active ingredients to the skin or mucosa
EP2624708B1 (en) * 2010-10-05 2021-09-22 Drylet, Inc. Composition and method for delivery of substances in a dry mode having a surface layer
US10821085B2 (en) * 2010-12-07 2020-11-03 Kimberly-Clark Worldwide, Inc. Wipe coated with a botanical composition having antimicrobial properties
ES2528378T3 (en) * 2010-12-23 2015-02-09 Dupont Nutrition Biosciences Aps Microbicidal composition
US9296989B2 (en) 2011-04-04 2016-03-29 Drylet Llc Composition and method for delivery of living cells in a dry mode having a surface layer
US20130095211A1 (en) * 2011-10-13 2013-04-18 Pepsico, Inc. Emulsions and Food Products Comprising Same and Methods for the Manufacture Thereof
KR101428848B1 (en) * 2012-03-27 2014-08-13 중앙대학교 산학협력단 Anti bacterial food preservative composition comprising thymol, nisin, acetic acid
AU2013350329A1 (en) * 2012-11-26 2015-07-02 Progel Pty Ltd Coating composition
WO2014082132A1 (en) 2012-11-29 2014-06-05 Progel Pty Ltd Microparticles comprising a probiotic, cross-linkable reagent, a denatured protein, polyol plasticiser and trehalose
US8859005B2 (en) * 2012-12-03 2014-10-14 Intercontinental Great Brands Llc Enteric delivery of functional ingredients suitable for hot comestible applications
GB201411194D0 (en) * 2014-06-24 2014-08-06 Dupont Nutrition Biosci Aps Animal feed and aqua feed
US20160158174A1 (en) * 2014-12-09 2016-06-09 Intercontinental Great Brands Llc Enteric-Coated Functional Food Ingredients And Methods For Making The Enteric-Coated Functional Food Ingredients
CZ308145B6 (en) * 2016-12-21 2020-01-22 Agrotest Fyto, S.R.O. Fungicidal plant protection product based on essential oil of Thymus vulgaris, production and use
US11440853B2 (en) 2017-02-28 2022-09-13 Drylet, Inc. Systems, methods, and apparatus for increased wastewater effluent and biosolids quality
WO2019195952A1 (en) 2018-04-13 2019-10-17 Pontificia Universidad Católica De Chile Synergic composition for keeping fish and seafood fresh
CN109173946B (en) * 2018-07-25 2020-09-01 浙江科技学院 Sodium alginate chitosan microcapsule containing polylysine and Nisin and preparation method thereof
CN109619487A (en) * 2018-10-26 2019-04-16 华中农业大学 Composition and preparation method thereof with function of relaxing bowel
WO2020101461A1 (en) 2018-11-13 2020-05-22 한국화학연구원 Organoid produced using carrier for cell culture, and method for evaluating drug toxicity using same
KR102154565B1 (en) * 2018-11-13 2020-09-10 한국화학연구원 Microcapsule containing natural oil and method for preparing thereof
CN110367341B (en) * 2019-08-09 2022-05-24 镇江市智农食品有限公司 Vegetable oil microcapsule powder applied to grain granules and preparation method thereof
US11559058B2 (en) 2019-09-20 2023-01-24 Kalamazoo Holdings, Inc. Synergistic antimicrobial effects among rosemary extract, cultured dextrose and buffered vinegar
CO2019011687A1 (en) 2019-10-22 2020-07-31 Alpina Productos Alimenticios S A Probiotic microcapsule
CN113881745A (en) * 2021-10-22 2022-01-04 四川农业大学 Preparation method of pH-responsive Zanthoxylum bungeanum antibacterial peptide microcapsules
CN114540112B (en) * 2022-01-18 2023-06-06 广东省农业科学院蚕业与农产品加工研究所 A kind of gardenia oil rich in crocin-I and its preparation method and application
CN115088845A (en) * 2022-06-13 2022-09-23 山东省农业科学院 1,3-Diglyceride microcapsules and preparation method thereof
WO2024046997A1 (en) * 2022-09-01 2024-03-07 Microcaps Ag Method for drying capsules
KR102705331B1 (en) * 2024-01-18 2024-09-12 주식회사 가드니아 A method of manufacturing frozen dough having the effect of reducing yeast death
CN118063808B (en) * 2024-03-27 2025-09-23 华南理工大学 Cinnamon essential oil-bagasse cellulose microspheres with sustained-release antibacterial effect, preparation method and application thereof
CN118203045A (en) * 2024-04-02 2024-06-18 华南理工大学 Double-packaging antibacterial gel, preparation method thereof and application thereof in fresh-keeping of perishable fruits
CN119097754B (en) * 2024-11-06 2025-03-18 中国计量大学 Antibacterial dressing containing plant essential oil

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3679434A (en) * 1970-07-13 1972-07-25 Mayer & Co Inc O Method of preparing fresh uncured meat products
US5084293A (en) * 1990-06-26 1992-01-28 Kalamazoo Holdings, Inc. Activated ascorbic acid antioxidant compositions and carotenoids, fats, and foods stabilized therewith
US5139787A (en) * 1989-01-19 1992-08-18 Wm. Wrigley Jr. Company Gum composition containing dispersed porous beads containing active chewing gum ingredients and method
US20020173436A1 (en) * 2000-09-20 2002-11-21 Steffen Sonnenberg Multiphase soaps
US20050067726A1 (en) * 2002-11-04 2005-03-31 Nianxi Yan Microcapsules having multiple shells and method for the preparation thereof

Family Cites Families (61)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3187019A (en) 1964-01-24 1965-06-01 Abbott Lab Brominated oils
US3576759A (en) 1968-04-12 1971-04-27 Ncr Co Process for en masse production of spherules by desiccation
GB8522963D0 (en) 1985-09-17 1985-10-23 Biocompatibles Ltd Microcapsules
US4950432A (en) 1987-10-16 1990-08-21 Board Of Regents, The University Of Texas System Polyene microlide pre-liposomal powders
ATE101490T1 (en) * 1988-06-22 1994-03-15 Applied Microbiology Inc NISIN COMPOSITIONS FOR USE AS ENHANCED BROAD-SPECTRUM BACTERICIDES.
NZ244737A (en) * 1989-02-21 1993-09-27 Viskase Corp Food packaging polymeric film containing antibiotic material; method of treating foodstuff and food casing therefor
US5032404A (en) * 1989-02-23 1991-07-16 Board Of Regents, The University Of Texas System Lipsome-incorporation of polyenes
US4980163A (en) * 1989-03-01 1990-12-25 Public Health Research Institute Of The City Of New York Novel bacteriocin compositions for use as enhanced broad range bactericides and methods of preventing and treating microbial infection
JPH02257866A (en) 1989-03-31 1990-10-18 San Purasuto Mikasa:Kk Preserving agent of food
US5204029A (en) * 1989-09-25 1993-04-20 Morgan Food Products, Inc. Methods of encapsulating liquids in fatty matrices, and products thereof
NZ237464A (en) 1990-03-21 1995-02-24 Depotech Corp Liposomes with at least two separate chambers encapsulating two separate biologically active substances
US5580573A (en) * 1991-02-01 1996-12-03 E. R. Squibb And Sons, Inc. Temperature activated controlled release
US5215757A (en) 1991-03-22 1993-06-01 The Procter & Gamble Company Encapsulated materials
RU2099087C1 (en) 1991-12-27 1997-12-20 Владивостокский государственный медицинский институт Method of antibiotic-containing liposome preparing
US5445949A (en) 1992-05-19 1995-08-29 Gist-Brocades N.V. Large scale separation and purification of fermentation product
GB2275194A (en) 1993-02-18 1994-08-24 Hung Yung Feng Plant Extract Disinfectant
US5472684A (en) * 1993-06-02 1995-12-05 Colgate Palmolive Company Oral compositions for plaque and gingivitis
CA2125914A1 (en) 1993-06-25 1994-12-26 Pharmacia Corporation Oil-coated microparticulated gellan gum
JP3040282B2 (en) 1993-07-30 2000-05-15 アサマ化成株式会社 Food preservatives
JP3042573B2 (en) 1993-07-30 2000-05-15 アサマ化成株式会社 Food preservatives
ATE311748T1 (en) 1993-09-29 2005-12-15 Dsm Ip Assets Bv MODIFIED FORMS OF NATAMYCIN, METHOD FOR THE PRODUCTION THEREOF AND ANTIFUNGAL COMPOSITIONS CONTAINING THEM
ES2126020T3 (en) 1994-06-16 1999-03-16 Nestle Sa INHIBITION OF THE GROWTH OF BACTERIA.
IL110943A (en) 1994-09-13 1997-02-18 Univ Ramot Compositions comprising an inhibitor of cholesterol synthesis for the treatment of skin disorders
EP0770336B1 (en) 1995-10-24 1997-07-23 Societe Des Produits Nestle S.A. Meat incorporation
JP3555640B2 (en) * 1996-05-10 2004-08-18 ライオン株式会社 Multicapsulated microcapsules containing natural carotenoids, tablets, food and pharmaceutical compounds
US5811114A (en) 1996-06-12 1998-09-22 E-L Management Corp. Stabilized hinokitiol and compositions containing same
US5895680A (en) * 1996-06-19 1999-04-20 Thomas J. Lipton Foodstuff preservation
US5738888A (en) 1996-06-20 1998-04-14 Thomas J. Lipton Co., Division Of Conopco, Inc. Beverage preservation
ATE363214T1 (en) 1997-03-14 2007-06-15 Dsm Ip Assets Bv SOLUBLE NATAMYCIN PROTEIN COMPLEX
AU3272597A (en) 1997-06-12 1998-12-30 Antonio Sacchetti Natural broad-spectrum antibiotic
US6083921A (en) * 1998-01-12 2000-07-04 Xu; Kai Jian Pharmaceutical compositions and method of using same
US6126974A (en) 1998-03-13 2000-10-03 Protein X Technologies Int'l Inc. Anti-caking anti-mycotic food ingredient and process for producing the same
AR014765A1 (en) 1998-03-23 2001-03-28 Gen Mills Marketing Inc COMPOSITION OF EDIBLE MATRIX WITH CHEATABLE TEXTURE, EDIBLE AND CHEATABLE PRODUCT, EDIBLE COMPOSITION, FOOD COVERAGE AND METHOD FOR THE MANUFACTURE OF EDIBLE PRODUCTS
US6033705A (en) 1998-07-08 2000-03-07 Isaacs; Charles E. Method for treating foodstuffs to reduce or prevent microbial activity
DE19853944A1 (en) 1998-11-24 2000-05-25 Bourdichon Alain Jacques Use of diminazene diaceturate or pentamidine for treating malaria
AU764855B2 (en) * 1998-12-15 2003-09-04 Rhodia Inc. Broad-range antibacterial composition
IN190017B (en) 1999-01-25 2003-05-31 Panacea Biotech Ltd
US6294192B1 (en) 1999-02-26 2001-09-25 Lipocine, Inc. Triglyceride-free compositions and methods for improved delivery of hydrophobic therapeutic agents
RU2158587C1 (en) 1999-05-11 2000-11-10 Ставропольское научно-производственное объединение "Пульс" Antibacterial agent for treatment of farm animals and poultry, method of preventing and treating chicken suffering from bacterial- origin diseases, method of treating bacterial-origin respiratory diseases in calves, and method of preventing cattle tuberculosis
US6451365B1 (en) * 2000-07-14 2002-09-17 Rhodia Inc. Antibacterial composition for control of gram positive bacteria in food applications
BR0012423A (en) * 1999-07-14 2002-07-02 Rhodia Antibacterial composition and method for controlling gram-positive bacteria for application in food
US6291436B1 (en) * 1999-07-16 2001-09-18 International Fiber Corporation Direct action anti-mycotic
EP1221955B9 (en) 1999-09-25 2005-11-30 University Of Iowa Research Foundation Immunostimulatory nucleic acids
US6500463B1 (en) 1999-10-01 2002-12-31 General Mills, Inc. Encapsulation of sensitive components into a matrix to obtain discrete shelf-stable particles
JO2178B1 (en) 1999-10-19 2003-04-23 اف . هوفمان لاروش ايه جي Treatment of emphysema using rar selective retinoid antagonists
US6375968B1 (en) * 1999-10-22 2002-04-23 3M Innovative Properties Company Encapsulated active material immobilized in hydrogel microbeads
JP2001172159A (en) 1999-12-20 2001-06-26 Lion Corp Hypoallergenic antibacterial cosmetic
US6312741B1 (en) 2000-02-22 2001-11-06 Balchem Corporation Encapsulated food acids for preservation of baked goods
WO2002026911A1 (en) * 2000-09-27 2002-04-04 Microtek Laboratories, Inc. Macrocapsules containing microencapsulated phase change materials
CN1313070C (en) 2001-01-16 2007-05-02 荷兰联合利华有限公司 Oral composition
NZ527902A (en) 2001-03-02 2005-06-24 Kalsec Inc Labiatae herb extracts and hop extracts for extending the color life and inhibiting the growth of microorganisms in fresh meat, fish and poultry
US20020192352A1 (en) 2001-04-24 2002-12-19 Mccormick & Company, Inc. Fat encapsulation compositions and method of preparing the same
EP1395246A1 (en) 2001-05-23 2004-03-10 Institut National de la Recherche Scientifique Biocompatible compositions as carriers or excipients for pharmaceutical and nutraceutical formulations and for food protection
DK1423023T3 (en) * 2001-07-13 2007-04-10 Danisco Composition with bacteriostatic and bactericidal activity against bacterial spores and vegetative cells and methods of treating foodstuffs thereby
CN1235728C (en) 2001-08-30 2006-01-11 蒋贵华 Middle-density fibre board and its production method
EP1369045A3 (en) 2002-05-28 2004-02-25 Viskase Corporation Films and casing having anti-listeria properties
US7014878B2 (en) 2002-07-18 2006-03-21 Kraft Foods Holdings, Inc. Refrigerated extended shelf-life bread products
US7247330B2 (en) 2002-07-23 2007-07-24 Kraft Foods Holdings, Inc. Method for controlling microbial contamination of a vacuum-sealed food product
US20040109927A1 (en) 2002-11-27 2004-06-10 Ang Jit Fu Carbonate-based anti-caking agent with reduced gas release properties
US7090882B2 (en) 2003-06-12 2006-08-15 Cargill, Incorporated Antimicrobial salt solutions for food safety applications
GB2388581A (en) 2003-08-22 2003-11-19 Danisco Coated aqueous beads

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3679434A (en) * 1970-07-13 1972-07-25 Mayer & Co Inc O Method of preparing fresh uncured meat products
US5139787A (en) * 1989-01-19 1992-08-18 Wm. Wrigley Jr. Company Gum composition containing dispersed porous beads containing active chewing gum ingredients and method
US5084293A (en) * 1990-06-26 1992-01-28 Kalamazoo Holdings, Inc. Activated ascorbic acid antioxidant compositions and carotenoids, fats, and foods stabilized therewith
US20020173436A1 (en) * 2000-09-20 2002-11-21 Steffen Sonnenberg Multiphase soaps
US20050067726A1 (en) * 2002-11-04 2005-03-31 Nianxi Yan Microcapsules having multiple shells and method for the preparation thereof

Cited By (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2009278419B2 (en) * 2008-08-04 2015-01-15 Mitsubishi Chemical Corporation Antibacterial agent and disinfecting method
US20110151034A1 (en) * 2008-08-04 2011-06-23 Mitsubishi Chemical Corporation Antibacterial agent and disinfecting method
US20100160224A1 (en) * 2008-10-14 2010-06-24 David Thomas Shelf-stable consumable compositions containing probiotic-mimicking elements and methods of preparing and using the same
US20220039412A1 (en) * 2009-10-15 2022-02-10 Dupont Nutrition Biosciences Aps Anti-oxidant composition
WO2012142077A3 (en) * 2011-04-11 2014-05-01 Kemin Industries, Inc. Use of propionic acid as an antimicrobial
US10159268B2 (en) 2013-02-08 2018-12-25 General Mills, Inc. Reduced sodium food products
US11540539B2 (en) 2013-02-08 2023-01-03 General Mills, Inc. Reduced sodium food products
US20160157482A1 (en) * 2013-05-07 2016-06-09 Kemin Industries, Inc. Antimicrobial Compositions Containing Carvacrol and Thymol
WO2016128508A1 (en) * 2015-02-11 2016-08-18 Chr. Hansen A/S Reduction of the concentration of gram-negative bacteria in a fermented food product by the combination of red wine extract and a culture comprising at least one bacteriocin-producing lactic acid bacterial strain
US10952448B2 (en) * 2015-02-11 2021-03-23 Chr. Hansen A/S Reduction of the concentration of gram-negative bacteria in a fermented food product by the combination of red wine extract and a culture comprising at least one bacteriocin-producing lactic acid bacterial strain
US11930833B2 (en) 2017-02-14 2024-03-19 Kraft Foods Group Brands Llc Process for maintaining freshness of vegetable pieces
US11793223B2 (en) 2018-03-09 2023-10-24 Conopco Inc. Antioxidant composition
CN111389315A (en) * 2020-03-27 2020-07-10 南京芬之怡生物科技有限公司 Green impurity-removing purifying agent and preparation method thereof

Also Published As

Publication number Publication date
US20160100588A1 (en) 2016-04-14
JP2007503215A (en) 2007-02-22
JP4926707B2 (en) 2012-05-09
US10271557B2 (en) 2019-04-30
ES2481167T3 (en) 2014-07-29
US20070042184A1 (en) 2007-02-22
DK1656026T3 (en) 2014-07-14

Similar Documents

Publication Publication Date Title
US10271557B2 (en) Composition comprising a bacteriocin and an extract from a plant of the Labiatae family
EP1656026B1 (en) Composition comprising a bacteriocin and an extract from a plant of the labiatae family
Jay et al. Modern food microbiology
Davidson et al. Chemical preservatives and natural antimicrobial compounds
AU2008294411B2 (en) Composition
DK2654440T3 (en) MICROBICID COMPOSITION
US20150140186A1 (en) Clostridium botulinum control in midly processed refrigerated food products
WO2005104878A1 (en) Anti-microbial composition
JP2004506403A (en) Antimicrobial composition for controlling Gram-positive bacteria used in food products
US10327463B2 (en) Composition and methods to control the outgrowth of pathogens and spoilage microorganisms in high moisture and low sodium systems
US20130287918A1 (en) Microbicidal composition
JP2004506403A5 (en)
EP1796487B1 (en) The use of glycine and/or glycine derivates as antibacterial agent against gram negative bacterial pathogens in foods and/or drinks
JP2006325590A (en) Synergistic antibacterial system
AU2016248231B2 (en) Composition and methods to control the outgrowth of pathogens and spoilage microorganisms in high moisture and low sodium systems
MXPA06002060A (en) Composition comprising a bacteriocin and an extract from a plant of the labiatae family.
US20060127546A1 (en) Use of glycine and/or glycine derivatives as antibacterial agent against gram negative bacterial pathogens in foods and/or drinks
Ray et al. Antifungal food additives
Kuley et al. Microbial based preservatives
Shen Control of Foodborne Pathogens by Hops Beta Acids in Food Systems
Singh et al. Food Biopreservatives

Legal Events

Date Code Title Description
AS Assignment

Owner name: DANISCO A/S, DENMARK

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:COYNE, BOB;FARAGHER, JOHN;GOUIN, SEBASTIEN;AND OTHERS;REEL/FRAME:018424/0753;SIGNING DATES FROM 20060821 TO 20060918

AS Assignment

Owner name: DUPONT NUTRITION BIOSCIENCES APS, DENMARK

Free format text: CHANGE OF NAME;ASSIGNOR:DANISCO A/S;REEL/FRAME:028334/0340

Effective date: 20120514

STCB Information on status: application discontinuation

Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION